<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">87414</article-id><article-id pub-id-type="doi">10.7554/eLife.87414</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.87414.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-309519"><name><surname>Mastwal</surname><given-names>Surjeet</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-309520"><name><surname>Li</surname><given-names>Xinjian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-309521"><name><surname>Stowell</surname><given-names>Rianne</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309522"><name><surname>Manion</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309523"><name><surname>Zhang</surname><given-names>Wenyu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309524"><name><surname>Kim</surname><given-names>Nam-Shik</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206601"><name><surname>Yoon</surname><given-names>Ki-Jun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2985-2541</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-105045"><name><surname>Song</surname><given-names>Hongjun</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149016"><name><surname>Ming</surname><given-names>Guo-Li</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-84630"><name><surname>Wang</surname><given-names>Kuan Hong</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2249-5417</contrib-id><email>kuanhong_wang@urmc.rochester.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04xeg9z08</institution-id><institution>Unit on Neural Circuits and Adaptive Behaviors, National Institute of Mental Health</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00trqv719</institution-id><institution>Department of Neuroscience, Del Monte Institute for Neuroscience, University of Rochester Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>West</surname><given-names>Anne E</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00py81415</institution-id><institution>Duke University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wong</surname><given-names>Ma-Li</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040kfrw16</institution-id><institution>State University of New York Upstate Medical University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>13</day><month>10</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP87414</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-03-21"><day>21</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-02-24"><day>24</day><month>02</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.02.03.526987"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-06-01"><day>01</day><month>06</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87414.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-09-25"><day>25</day><month>09</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.87414.2"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-87414-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-87414-figures-v1.pdf"/><abstract><p>Dopamine system dysfunction is implicated in adolescent-onset neuropsychiatric disorders. Although psychosis symptoms can be alleviated by antipsychotics, cognitive symptoms remain unresponsive and novel paradigms investigating the circuit substrates underlying cognitive deficits are critically needed. The frontal cortex and its dopaminergic input from the midbrain are implicated in cognitive functions and undergo maturational changes during adolescence. Here, we used mice carrying mutations in <italic>Arc</italic> or <italic>Disc1</italic> to model mesofrontal dopamine circuit deficiencies and test circuit-based neurostimulation strategies to restore cognitive functions. We found that in a memory-guided spatial navigation task, frontal cortical neurons were activated coordinately at the decision-making point in wild-type but not <italic>Arc</italic>-/- mice. Chemogenetic stimulation of midbrain dopamine neurons or optogenetic stimulation of frontal cortical dopamine axons in a limited adolescent period consistently reversed genetic defects in mesofrontal innervation, task-coordinated neuronal activity, and memory-guided decision-making at adulthood. Furthermore, adolescent stimulation of dopamine neurons also reversed the same cognitive deficits in <italic>Disc1</italic>+/- mice. Our findings reveal common mesofrontal circuit alterations underlying the cognitive deficits caused by two different genes and demonstrate the feasibility of adolescent neurostimulation to reverse these circuit and behavioral deficits. These results may suggest developmental windows and circuit targets for treating cognitive deficits in neurodevelopmental disorders.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>adolescence</kwd><kwd>dopamine circuit</kwd><kwd>frontal cortex</kwd><kwd>chemogenetic</kwd><kwd>optogenetic</kwd><kwd>cognitive deficits</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>ZIAMH002897</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Kuan Hong</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008091</institution-id><institution>University of Rochester</institution></institution-wrap></funding-source><award-id>Del Monte Institute for Neuroscience</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Kuan Hong</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F32MH124298</award-id><principal-award-recipient><name><surname>Stowell</surname><given-names>Rianne</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U19MH106434</award-id><principal-award-recipient><name><surname>Song</surname><given-names>Hongjun</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35NS097370</award-id><principal-award-recipient><name><surname>Ming</surname><given-names>Guo-Li</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01MH127737</award-id><principal-award-recipient><name><surname>Wang</surname><given-names>Kuan Hong</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Frontal cortical circuit alterations and cognitive deficits identified in mouse genetic models are reversed by chemogenetic or optogenetic stimulation of the mesocortical dopamine circuit in an adolescent period.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Dysfunctions of the dopamine system are commonly implicated in neuropsychiatric disorders such as schizophrenia and substance-use disorders (<xref ref-type="bibr" rid="bib43">Insel, 2010</xref>; <xref ref-type="bibr" rid="bib99">Saha et al., 2005</xref>; <xref ref-type="bibr" rid="bib119">Volkow et al., 2018</xref>). In addition, the treatment effect of antipsychotic medication is related to its effectiveness in blocking dopamine D2 receptors (<xref ref-type="bibr" rid="bib41">Howes and Kapur, 2009</xref>; <xref ref-type="bibr" rid="bib124">Weinstein et al., 2017</xref>). However, psychiatric symptoms include not only psychosis that can be treated by antipsychotics, but also cognitive disabilities in executive functions and memory (<xref ref-type="bibr" rid="bib38">Green, 2007</xref>; <xref ref-type="bibr" rid="bib74">Miyamoto et al., 2005</xref>; <xref ref-type="bibr" rid="bib124">Weinstein et al., 2017</xref>). While current antipsychotic therapies based on D2 antagonism have little effect on cognitive disabilities (<xref ref-type="bibr" rid="bib6">Barbui et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">Davidson et al., 2009</xref>; <xref ref-type="bibr" rid="bib48">Keefe et al., 2004</xref>; <xref ref-type="bibr" rid="bib74">Miyamoto et al., 2005</xref>), frontal cortical dopamine deficits are reported in schizophrenia and the role of frontal cortical dopamine D1 receptor activation in cognitive function has been demonstrated in animal studies (<xref ref-type="bibr" rid="bib5">Arnsten, 1997</xref>; <xref ref-type="bibr" rid="bib16">Castner et al., 2000</xref>; <xref ref-type="bibr" rid="bib106">Slifstein et al., 2015</xref>; <xref ref-type="bibr" rid="bib118">Vijayraghavan et al., 2007</xref>). Unfortunately, due to safety and bioavailability issues, very few D1 receptor agonists have progressed to clinical testing (<xref ref-type="bibr" rid="bib34">Girgis et al., 2016</xref>; <xref ref-type="bibr" rid="bib70">Marder, 2006</xref>; <xref ref-type="bibr" rid="bib112">Tamminga, 2006</xref>). The long-standing difficulty of developing effective pharmacological treatments for cognitive symptoms suggests the necessity of new investigative approaches, such as evaluating the underlying neural circuitry and its potential for modification.</p><p>Dopamine regulates a multitude of behavioral functions through different anatomical pathways from dopaminergic neurons in the midbrain ventral tegmental area (VTA) and substantia nigra to cortical and subcortical target regions (<xref ref-type="bibr" rid="bib9">Beier et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Björklund and Dunnett, 2007</xref>; <xref ref-type="bibr" rid="bib59">Lerner et al., 2015</xref>; <xref ref-type="bibr" rid="bib123">Watabe-Uchida et al., 2012</xref>). The mesofrontal pathway innervates the frontal cortex and an optimal level of dopamine is important for normal frontal circuit functions (<xref ref-type="bibr" rid="bib4">Arnsten et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Floresco, 2013</xref>; <xref ref-type="bibr" rid="bib94">Robbins, 2000</xref>; <xref ref-type="bibr" rid="bib117">Vander Weele et al., 2018</xref>). The frontal cortical circuit integrates dopaminergic signals with multisensory and memory information to control behavioral actions (<xref ref-type="bibr" rid="bib20">Dalley et al., 2004</xref>; <xref ref-type="bibr" rid="bib30">Fuster, 2008</xref>; <xref ref-type="bibr" rid="bib73">Miller and Cohen, 2001</xref>; <xref ref-type="bibr" rid="bib98">Rushworth et al., 2012</xref>). Together, the frontal cortex and its dopaminergic input form a critical substrate for cognitive functions and a hypoactive frontal cortical dopamine system is found in schizophrenia patients (<xref ref-type="bibr" rid="bib106">Slifstein et al., 2015</xref>; <xref ref-type="bibr" rid="bib124">Weinstein et al., 2017</xref>). Genetic disruptions of several genes involved in synaptic functions related to psychiatric disorders, such as <italic>Arc</italic> and <italic>Disc1</italic>, lead to hypoactive mesofrontal dopaminergic input in mice (<xref ref-type="bibr" rid="bib29">Fromer et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>; <xref ref-type="bibr" rid="bib91">Purcell et al., 2014</xref>; <xref ref-type="bibr" rid="bib125">Wen et al., 2014</xref>). Although there are many differences between these mouse lines and specific human disease states, these mice offer opportunities to test whether genetic deficits in frontal cortex function can be reversed through circuit interventions.</p><p>Adolescence is an important period for the development of cognitive control functions and exploration behaviors (<xref ref-type="bibr" rid="bib19">Dahl et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Larsen and Luna, 2018</xref>; <xref ref-type="bibr" rid="bib108">Spear, 2011</xref>). Cognitive control deficits often emerge during adolescence as a characteristic manifestation of several psychiatric disorders including schizophrenia and substance-use disorders (<xref ref-type="bibr" rid="bib43">Insel, 2010</xref>; <xref ref-type="bibr" rid="bib87">Paus et al., 2008</xref>; <xref ref-type="bibr" rid="bib119">Volkow et al., 2018</xref>). Developmental studies of the mesofrontal dopamine projection in both non-human primates and rodents suggest that this pathway exhibits a protracted maturation through adolescence (<xref ref-type="bibr" rid="bib47">Kalsbeek et al., 1988</xref>; <xref ref-type="bibr" rid="bib52">Lambe et al., 2000</xref>; <xref ref-type="bibr" rid="bib80">Naneix et al., 2013</xref>; <xref ref-type="bibr" rid="bib96">Rosenberg and Lewis, 1995</xref>; <xref ref-type="bibr" rid="bib127">Ye et al., 2017</xref>). Importantly, the structure and function of the mesofrontal circuit are malleable to experience; activity-dependent modification during adolescence and adolescent exposure to substances of abuse can produce long-lasting deficits (<xref ref-type="bibr" rid="bib46">Jobson et al., 2019</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">Reynolds et al., 2019</xref>; <xref ref-type="bibr" rid="bib120">Walker et al., 2017</xref>). However, it is unknown whether adolescent intervention in this pathway can induce long-lasting circuit changes conducive for the recovery of cognitive function from genetic deficits.</p><p>Mouse genetic models of frontal dopamine deficits and the adolescence malleability of this circuit present opportunities to investigate the cellular substrates underlying cognitive deficits and test potential intervention strategies (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>). In this study, using single-cell resolution neuronal ensemble imaging in freely behaving animals, we identified a disruption of neuronal coordination in frontal cortex that is associated with cognitive impairment in mouse models. Furthermore, taking advantage of the activity-dependent adolescent plasticity in the mesofrontal circuit, we developed targeted chemogenetic and optogenetic neuromodulation techniques that are able to reverse the neural coordination and cognitive behavioral deficits in adult animals. Our results demonstrate the capability of adolescent frontal dopamine circuit stimulation to achieve long-term reversal of cognitive deficits and suggest potential translational targets and strategies for psychiatric treatments.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characterization of cognitive and mesofrontal innervation deficits in <italic>Arc</italic> mutant mice</title><p>We first used an <italic>Arc</italic> mutant model of a hypofunctioning mesofrontal circuit (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>) for behavioral, anatomical tracing, and neural activity imaging studies. To assess whether genetic disruption of <italic>Arc</italic> (by knocking in a GFP reporter cassette; <xref ref-type="bibr" rid="bib121">Wang et al., 2006</xref>) affects cognitive control of behavior, we examined wild-type and <italic>Arc</italic> homozygous mutant mice in a Y-maze spatial navigation task. This task takes advantage of the innate spatial navigation ability of mice and does not require extensive pretraining, making it well suited for both developmental and adult testing (<xref ref-type="bibr" rid="bib10">Belforte et al., 2010</xref>; <xref ref-type="bibr" rid="bib51">Lalonde, 2002</xref>; <xref ref-type="bibr" rid="bib93">Richman et al., 1986</xref>). Wild-type mice explore the three arms of the maze using a memory-based decision-making strategy, preferring to visit a new arm instead of the most recently visited arm (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). The percentage of new arm visits out of the total arm visits is referred to as ‘alternation percentage’, which is approximately 67% in wild-type mice and significantly above the chance level from random exploration (50%). By contrast, the alternation percentage in <italic>Arc</italic> mutant mice is significantly reduced toward the chance level (p=0.001, <italic>t</italic>-test, t(15) = 3.975, <italic>WT</italic>: 67.2 ± 2.6%, vs. <italic>Arc</italic>-/-: 53.4 ± 2.3%, N=8 and 9 mice, respectively; <xref ref-type="fig" rid="fig1">Figure 1b</xref>). <italic>Arc</italic> mutant mice showed a similar number of total arm entries as the wild-type mice (<xref ref-type="fig" rid="fig1">Figure 1c</xref>), suggesting that the <italic>Arc</italic> mutation did not affect the overall locomotor activity or motivation level. Taken together, these results suggest that <italic>Arc</italic> mutant mice have a deficit in memory-guided choice behaviors.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Characterization of cognitive and mesofrontal deficits in <italic>Arc</italic> mutant mice.</title><p>(<bold>a</bold>) Diagram showing the navigation choices for mice in a Y-maze. At the center of the maze, a mouse has a choice to enter either a new arm (alternation) or a previously visited old arm. (<bold>b</bold>) Alternation percentage in the Y-maze task showing significant reduction in the <italic>Arc</italic>-/- animals compared to wild-type animals (**p=0.001, <italic>t</italic>-test, t(15)=3.975, <italic>WT</italic> N=8, <italic>Arc</italic>-/- N=9 mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>c</bold>) Total arm entries are comparable between <italic>Arc</italic>-/- and <italic>WT</italic>. (<bold>d</bold>) Top, schematic for AAV injection in Th-Cre animals to label dopaminergic neurons. Bottom, confocal image showing tdTomato (red) and SypGFP (green) labeling in the ventral tegmental area (VTA). Scale bar, 100 µm. (<bold>e</bold>) Left, confocal image showing labeled dopaminergic axons in the frontal cortex. The dotted line indicates the region-of-interest for M2. Scale bar, 100 µm. Right, zoomed-in region showing labeled axons (tdTomato, red) and boutons (tdTomato+SypGFP, yellow). Scale bar, 20 µm. (<bold>f, g</bold>) The normalized axon length (<bold>f</bold>) is not significantly different. The normalized bouton density (<bold>g</bold>) is significantly reduced in <italic>Arc</italic>-/- animals compared to <italic>WT</italic> (*p=0.034, <italic>t</italic>-test, t(12)=2.393, N=7 mice for each group). The axon length is normalized by the number of labeled cells in VTA, the bouton density is normalized by the axon length, and both are expressed as a percentage of the group average in <italic>WT</italic> mice. All the error bars indicate SEM.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Characterization of cognitive and mesofrontal deficits in <italic>Arc</italic> mutant mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Chemogenetic inhibition of M2 frontal cortex reduces alternation in Y-maze.</title><p>(<bold>a</bold>) Confocal image showing expression of control mCherry or DREADD-Gi-mCherry in M2 frontal cortex. Scale bar, 500 µm. (<bold>b</bold>) Alternation in the Y-maze task showing significant reduction in the Gi animals compared to control animals (*p=0.017, <italic>t</italic>-test, t(10)=2.845, Gi N=6, Ctrl N=6, including three saline control in Gi-labeled mice (pink dots) and three mCherry control with CNO injection (red dots). These two control groups showed no significant difference, and their data were pooled together). (<bold>c</bold>) Total arm entries and (<bold>d</bold>) left-right turns (percentage of right turns shown) are not significantly different. All the error bars indicate SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Optimal performance in the Y-maze requires an intact frontal cortex and VTA (<xref ref-type="bibr" rid="bib23">Delatour and Gisquet-Verrier, 1996</xref>; <xref ref-type="bibr" rid="bib24">Divac et al., 1975</xref>; <xref ref-type="bibr" rid="bib89">Pioli et al., 2008</xref>). The M2 region of the frontal cortex plays an important role in action planning, generating the earliest neural signals among frontal cortical regions that are related to upcoming choice during spatial navigation (<xref ref-type="bibr" rid="bib110">Sul et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Sul et al., 2010</xref>). To verify the involvement of the M2 cortex in Y-maze alternation, we expressed the chemogenetic inhibitor DREADD-Gi (<xref ref-type="bibr" rid="bib97">Roth, 2016</xref>) in M2 with an adeno-associated viral (AAV) vector and used clozapine <italic>N</italic>-oxide (CNO) injection to inhibit M2 neural activity in wild-type mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). We found that the alternation percentage was significantly reduced in the DREADD-Gi animals compared with control animals (p=0.017, <italic>t</italic>-test, t(10)=2.845, Ctrl: 64.6 ± 1.8%, Gi: 54.1 ± 3.2%, N=6 for each group, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>), while other aspects of motor behaviors in this task were not affected (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1c and d</xref>). These results confirm the involvement of M2 frontal cortical neurons in memory-guided decision-making during the Y-maze task.</p><p>Dopaminergic input from the VTA is critical to optimal frontal cortical function in controlling cognitive processes (<xref ref-type="bibr" rid="bib4">Arnsten et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Floresco, 2013</xref>; <xref ref-type="bibr" rid="bib94">Robbins, 2000</xref>). While the prelimbic area has the highest level of dopaminergic terminals among frontal cortical regions, a robust presence of midbrain dopaminergic projections and dopamine release in the M2 frontal cortex have been well established by immunostaining, viral labeling, single-cell axon-tracing, and in vivo imaging of dopamine biosensors (<xref ref-type="bibr" rid="bib2">Aransay et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Berger et al., 1991</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>; <xref ref-type="bibr" rid="bib86">Patriarchi et al., 2018</xref>). We therefore examined the anatomical structure of the M2 dopaminergic projection to determine if this input was altered in <italic>Arc</italic> mutant mice.</p><p>Mesocortical dopamine neurons have much stronger tyrosine hydroxylase (TH) expression than dopamine transporter expression, which is different from mesostriatal dopamine neurons (<xref ref-type="bibr" rid="bib53">Lammel et al., 2008</xref>; <xref ref-type="bibr" rid="bib55">Lammel et al., 2015</xref>; <xref ref-type="bibr" rid="bib62">Li et al., 2013</xref>; <xref ref-type="bibr" rid="bib103">Sesack et al., 1998</xref>). In addition, TH immunoreactivity in the frontal cortex can label dopaminergic axons originated from the VTA, and ablation of VTA dopaminergic neurons removes this labeling (<xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib127">Ye et al., 2017</xref>). Accordingly, Th-Cre transgenic lines have been frequently used to label these neurons and study the mesocortical pathway (<xref ref-type="bibr" rid="bib26">Ellwood et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Gunaydin et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Lammel et al., 2012</xref>; <xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib117">Vander Weele et al., 2018</xref>).</p><p>We injected Cre-dependent AAV vectors into the VTA of Th-Cre mice to label dopaminergic axons with a cytoplasmic marker tdTomato, and the dopamine release sites in axonal boutons with a GFP reporter fused to synaptic vesicle protein synaptophysin (<xref ref-type="fig" rid="fig1">Figure 1d and e</xref>; <xref ref-type="bibr" rid="bib69">Manion et al., 2022</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>; <xref ref-type="bibr" rid="bib85">Oh et al., 2014</xref>; <xref ref-type="bibr" rid="bib122">Wang et al., 2017</xref>). Although the dopaminergic axon length in the M2 frontal cortex (normalized by the number of labeled cells in VTA) was not significantly different between <italic>Arc</italic> mutant and wild-type animals (<xref ref-type="fig" rid="fig1">Figure 1f</xref>), we found a significant reduction in the dopaminergic bouton density in this region in <italic>Arc</italic> mutant mice compared to wild-type animals (p=0.034, <italic>t</italic>-test, t(12)=2.393, <italic>WT</italic>: 100 ± 5%, <italic>Arc -/-</italic>: 84 ± 5%, N=7 for each group; bouton density normalized by axon length; <xref ref-type="fig" rid="fig1">Figure 1g</xref>). These results suggest that dopaminergic innervations of the M2 frontal cortex are reduced in <italic>Arc</italic> mutant mice, which agrees with our previous findings of reduced frontal dopamine release and mesofrontal activity in <italic>Arc-/-</italic> mice (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>). Our new results provide further anatomical evidence for a hypofunctional mesofrontal dopamine circuit in these mice.</p></sec><sec id="s2-2"><title>Task-coordinated frontal neuronal ensemble activity is disrupted in <italic>Arc</italic> mutant mice</title><p>To determine how M2 neuronal activities during Y-maze performance might be affected by <italic>Arc</italic> mutation and reduced dopaminergic input, we expressed a genetically encoded calcium indicator GCaMP6 (<xref ref-type="bibr" rid="bib18">Chen et al., 2013</xref>) in superficial layer (L2/3) M2 neurons and used a head-mounted miniaturized microscope (<xref ref-type="bibr" rid="bib32">Ghosh et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib64">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib122">Wang et al., 2017</xref>) to image task-related neuronal ensemble activity in adult wild-type and <italic>Arc-/-</italic> mice (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). The microscope lens was placed above the pial surface rather than inserted into the cortex to avoid damage of M2 neurons, and neuronal activities in superficial cortical layers were imaged (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a–c</xref>, <xref ref-type="video" rid="fig2video1">Figure 2—video 1</xref>). We found that the activity of individual M2 neurons occurred at various positions along the track during Y-maze navigation (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). An increased proportion of neurons showed peak activation when the wild-type animal was near the center of the maze before making an arm entry (<xref ref-type="fig" rid="fig2">Figure 2c</xref>). In contrast, this proportion was significantly reduced in <italic>Arc</italic> mutant mice compared to wild-type animals (p&lt;0.0001, chi-square test, <italic>WT</italic> 938 cells from 8 mice, <italic>Arc</italic>-/- 1338 cells from 7 mice). This effect is not due to a general reduction of neural activity in <italic>Arc-/-</italic> mice, because there is no difference between wild-type and <italic>Arc-/-</italic> mice in the average activity of neurons throughout the task period (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1d–f</xref>). In addition, there is no correlation between the average activity of neurons with alteration behaviors in Y-maze (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1j</xref>). Thus, these results suggest that the coordinated activation of M2 neurons before making a choice is disrupted in <italic>Arc</italic> mutant mice.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Task-coordinated frontal neuronal ensemble activity is disrupted in <italic>Arc</italic> mutant mice.</title><p>(<bold>a</bold>) Diagram showing the setup for miniaturized microscope imaging of frontal cortical activity in mice performing the Y-maze task. The example image represents the projection (by standard deviation of ΔF/F) of a calcium activity movie (~500 s), showing labeled M2 frontal cortical neurons. Scale bar, 100 µm. (<bold>b</bold>) Top, an example plot showing the positions of a wild-type mouse relative to the Y-maze center during navigation. Bottom, raster plot showing the calcium activity of M2 neurons simultaneously recorded during navigation. (<bold>c</bold>) Top, the average activity of individual frontal cortical neurons at binned positions relative to the center of Y-maze in <italic>WT</italic> (938 neurons from 8 animals) and <italic>Arc</italic>-/- (1338 neurons from 7 animals) animals. Bottom, the proportion of neurons showing maximal activation at each maze position. This proportion peaked right before the maze center in <italic>WT</italic> mice but reduced significantly in <italic>Arc</italic>-/- mice. Shaded areas indicate 95% confidence intervals. (<bold>d</bold>) Examples of neurons showing differential (alternation-selective, traces from three neurons on the left) or similar (non-selective, traces from three neurons on the right) activity between new and old arm visits. (<bold>e</bold>) The proportion of alternation-selective neurons peaked right before the maze center in <italic>WT</italic> mice but reduced significantly in <italic>Arc</italic>-/- mice. Shaded areas indicate 95% confidence intervals.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Task-coordinated frontal neuronal ensemble activity is disrupted in <italic>Arc</italic> mutant mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Imaging cortical neuronal activity in Y-maze alternation task with a miniaturized head-attached microscope.</title><p>(<bold>a</bold>) Schematic drawing of the outline of experimental procedures. (<bold>b</bold>) Confocal fluorescence images of coronal brain sections showing superficial layer cortical neurons that are labeled by infusion of AAV9-GCaMP6 virus from the pial surface. Left:10×, right: 20×. Scale bar, 100 µm. (<bold>c</bold>) Left: A representative standard deviation projection image of 15,000 frames collected over 8 min in the M2 frontal cortex of a freely moving mouse in a Y-maze. Right: The ΔF/F activity traces of labeled cortical neurons matched in color with the left image. Scale bar, 100 µm. (<bold>d–f</bold>) Quantifications of average calcium transient amplitude (<bold>d</bold>), frequency (<bold>e</bold>), and duration (<bold>f</bold>) in <italic>WT</italic> and <italic>Arc</italic>-/- mice during Y-maze exploration. Each dot on the plot represented the cell average from one mouse. No significant difference was detected. (<bold>d</bold>) p=0.548, <italic>t</italic>-test, t(13)=0.617; (<bold>e</bold>) p=0.117, <italic>t</italic>-test, t(13)=1.679; (<bold>f</bold>) p=0.264, <italic>t</italic>-test, t(13)=1.168. (<bold>g</bold>) Y-maze alternation percentage for animals in the miniscope imaging experiments, showing reduction in <italic>Arc</italic>-/- animals compared to <italic>WT</italic> (*p=0.047, <italic>t</italic>-test, t(13)=2.196, <italic>WT</italic> N=8, <italic>Arc</italic>-/- N=7 mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>h</bold>) Total entries. (<bold>i</bold>) Left-right turns (percentage of right turns shown) are not significantly different. (<bold>h</bold>) p=0.69, <italic>t</italic>-test, t(13)=0.408; (<bold>i</bold>) p=0.304, <italic>t</italic>-test, t(13)=1.07. All the error bars indicate SEM. (<bold>j</bold>) Pearson pairwise correlation between the frequency of calcium events and the alternation scores or total entries in WT, Arc-/-, and both genotype groups. No significant correlation was found.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig2-figsupp1-v1.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-87414-fig2-video1.mp4" id="fig2video1"><label>Figure 2—video 1.</label><caption><title>Frontal cortical neuronal ensemble activity in freely moving mice during Y-maze exploration.</title><p>Simultaneously recorded behavioral video of a mouse exploring a Y-maze (left) and calcium activity (ΔF/F) movie of M2 cortical neurons imaged through a head-attached miniaturized microscope (right).</p></caption></media></fig-group><p>To further examine how exploratory choices may be encoded in the activities of individual M2 neurons, we compared the neuronal activity patterns along the navigation trajectories leading to new arm visits versus old arm visits. Neurons selective for alternation were identified by differential neural activation between alternating and non-alternating paths (<xref ref-type="fig" rid="fig2">Figure 2d</xref>). This analysis showed that the proportion of alternation-selective neurons increased in the wild-type mice as the animal approached the maze center, but this increase was blunted in the <italic>Arc</italic> mutant animals (p&lt;0.0001, chi-square test, <xref ref-type="fig" rid="fig2">Figure 2e</xref>). These same mutant animals also showed a specific reduction of alternation choices in the Y-maze (p=0.047, <italic>t</italic>-test, t(13)=2.196, <italic>WT</italic>: 67.8 ± 4.4%, N=8 mice; <italic>Arc-/-</italic>: 54.5 ± 4.1%, N=7 mice, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1g–i</xref>), replicating the deficit we observed in separate groups of animals that did not carry the miniaturized microscope (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). Together, these results demonstrate that both task-related frontal cortical activity and memory-guided decision behavior are impaired in <italic>Arc</italic> mutant mice.</p></sec><sec id="s2-3"><title>Adolescent dopamine neuron stimulation leads to long-term reversal of mesofrontal circuit deficits</title><p>Given the hypofunctioning mesofrontal dopaminergic circuit in <italic>Arc</italic> mutant mice, we next investigated the possibility of developing neurostimulation strategies to restore normal circuit functions. The dopaminergic innervation in the mesofrontal circuit exhibits a protracted maturation from postnatal day 21 (P21) to P56 (<xref ref-type="bibr" rid="bib40">Hoops and Flores, 2017</xref>; <xref ref-type="bibr" rid="bib47">Kalsbeek et al., 1988</xref>; <xref ref-type="bibr" rid="bib79">Naneix et al., 2012</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>). P35–42 is in the center of this period and captures the mid-adolescent stage in rodents (<xref ref-type="bibr" rid="bib107">Spear, 2000</xref>). We have previously shown that increasing dopamine neuron activity by wheel running or optogenetic stimulation during this period, but not adulthood, can induce formation of mesofrontal dopaminergic boutons and enhance mesofrontal circuit activity in wild-type mice (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>). We therefore chose the P35–P42 adolescent window to stimulate the mesofrontal dopamine circuit and test the long-term effect of this intervention on the frontal circuit and memory-guided decision-making deficits in adult <italic>Arc</italic> mutant mice.</p><p>To stimulate dopamine neuron activity, we expressed chemogenetic activator DREADD-Gq (<xref ref-type="bibr" rid="bib1">Alexander et al., 2009</xref>) in the VTA dopamine cells using a combination of stereotaxically injected Cre-dependent AAV vectors and a Th-Cre transgenic mouse line (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>; <xref ref-type="fig" rid="fig3">Figure 3a</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a</xref>). CNO (1 mg/kg) was injected systemically to enhance the activity of DREADD-Gq-expressing dopamine neurons. To control for any potential off-target effect of CNO, another group of Th-Cre mice that expressed AAV-mCherry reporter in dopamine neurons also received CNO injection. Previous studies have shown that DREADD-Gq-induced neural activation reaches its peak approximately 1 hr after CNO injection and returns to baseline approximately 9 hr after injection (<xref ref-type="bibr" rid="bib1">Alexander et al., 2009</xref>). Increased VTA dopamine activity is known to enhance frontal cortical activity, which can be measured with calcium indicator GCaMP6 (<xref ref-type="bibr" rid="bib57">Lavin et al., 2005</xref>; <xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>). We validated the DREADD-Gq-induced enhancement of mesofrontal activity by examining M2 cortical activity with GCaMP6 before and after CNO injection in these mice (<xref ref-type="fig" rid="fig3">Figure 3a and b</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b</xref>). There was a significant increase in the M2 cortical activity measured 1 hr after the injection of CNO in DREADD-Gq animals, whereas no significant effect occurred in control mCherry animals (DREADD-Gq: 82±17% vs. mCherry Ctrl: 20 ± 14%, p=0.018, <italic>t</italic>-test, t(10)=2.814, N=6 for each group; <xref ref-type="fig" rid="fig3">Figure 3c</xref>). In addition, saline injection in DREADD-Gq-expressing mice did not alter M2 neural activity, and CNO-induced increase in M2 neural activity was suppressed by D1 antagonist SCH23390 (p=0.0002, N=7 for each group, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1c</xref>). These results confirmed CNO-induced activation of the mesofrontal dopaminergic circuit in DREADD-Gq animals.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Adolescent dopamine neuron stimulation leads to long-term reversal of mesofrontal circuit deficits.</title><p>(<bold>a</bold>) Schematic for labeling dopamine neurons with DREADD-Gq-mCherry and imaging frontal cortical activity with GCaMP6. The example image at the top shows a two-photon image of labeled cortical neurons. Scale bar, 20 μm. (<bold>b</bold>) Example traces of spontaneous cortical activity averaged from the whole image frame in control mCherry only (blue) and DREADD-Gq (red) animals before and 1 hr after clozapine <italic>N</italic>-oxide (CNO) injection. (<bold>c</bold>) Gq animals show significantly higher change in cortical activity after CNO injection compared to control mCherry only animals, suggesting CNO-induced activation of the mesofrontal circuit (*p=0.018, <italic>t</italic>-test, t(10)=2.814, N=6 mice for each group). Cortical activity is summarized by the standard deviation (SD) of the spontaneous activity traces. Activity change is calculated as (SD2-SD1)/SD1, where SD1 is before and SD2 after treatment. (<bold>d</bold>) Diagram showing experimental procedures to evaluate the effect of adolescent dopamine neuron stimulation on the structure of frontal dopaminergic projections. (<bold>e, f</bold>) Normalized axon length (<bold>e</bold>) is not significantly different. Normalized bouton density (<bold>f</bold>) is significantly increased in Gq animals compared to Ctrl (*p=0.013, <italic>t</italic>-test, t(18)=2.763, N=10 for each group). The axon length is normalized by the number of labeled cells in ventral tegmental area (VTA), the bouton density is normalized by the axon length, and both are expressed as a percentage of the group average in Ctrl mice. (<bold>g</bold>) Diagram showing procedures to determine the effect of adolescent dopamine neuron stimulation on mesofrontal circuit activity in <italic>Arc</italic>-/-;Th-Cre mice labeled with DREADD-Gq or mCherry-Ctrl. (<bold>h</bold>) Schematic showing the experimental setup to measure the mesofrontal circuit activity by VTA electrical stimulation and GCaMP6 imaging in the frontal cortex. (<bold>i</bold>) Time courses of cortical calcium signals in response to VTA stimulation in <italic>Arc</italic>-/-;mCherry-Ctrl and <italic>Arc</italic>-/-; DREADD-Gq mice. 1, 5, or 10 pulses of electrical stimuli (50 Hz) were delivered at 20 s after the start of imaging. The cortical calcium activity at each time point is represented by the change in image fluorescence relative to the baseline image fluorescence (ΔF/F). (5 pulse F(1,10)=6.0, *p=0.034, 10 pulse F(1,10)=9.5, *p=0.012, two-way ANOVA, N=6 mice per group).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Adolescent dopamine neuron stimulation leads to long-term reversal of mesofrontal circuit deficits.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Ventral tegmental area (VTA) expression of DREADD-Gq and validation of clozapine <italic>N</italic>-oxide (CNO)-induced cortical activation.</title><p>(<bold>a</bold>) Example confocal image of DREADD-Gq-mCherry labeling in the midbrain. Scale bar, 100 µm. (<bold>b</bold>) Top, example images showing standard deviation projection of in vivo two-photon calcium activity movies in the M2 frontal cortex. Bottom, example traces of spontaneous cortical activity in a representative sample of individual cells before and 1 hr after CNO injection in a DREADD-Gq animal. Scale bar, 20 µm. (<bold>c</bold>) Saline injection in DREADD-Gq-expressing mice did not alter M2 neural activity, and CNO-induced increase in M2 neural activity was suppressed by D1 antagonist SCH23390 (1 mg/kg, i.p.). Two injections (CNO-SAL, CNO-SCH, or SAL-SAL) were done in each animal. Three imaging sessions were conducted: before any injection, 1 hr after the first injection to allow CNO to take effect, and 30 min after the second injection to allow SCH to take effect. Cortical activity is summarized by the standard deviation (SD) of the spontaneous activity traces. Activity changes are calculated as (SD-SD<sub>0</sub>)/SD<sub>0</sub>, where SD<sub>0</sub> is before any drug or saline injection, and SD is after CNO, saline, or SCH23390 injection (two-way repeated measures ANOVA, group × treatment, F(2,18) = 8.9, p=0.0020; Sidak’s multiple comparison: CNO followed by SAL, p=0.5667; CNO followed by SCH, ***p=0.0002; SAL followed by SAL, p=0.8492; N=7 mice for each group).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig3-figsupp1-v1.tif"/></fig></fig-group><p>After the validation of activity enhancement by chemogenetic stimulation of dopamine neurons, we examined if this treatment would have any long-term effect on the circuit deficits in <italic>Arc</italic> mutant mice. Our previous work in wild-type adolescent mice showed that a single optogenetic stimulation session or a 2 hr wheel running session is sufficient to induce bouton formation in mesofrontal dopaminergic axons (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>). In this study, we sought to rescue existing structural and functional deficits in the mesofrontal dopaminergic circuits due to genetic mutations. Because previous studies suggested that an optimal level of dopamine is important for normal cognitive function (<xref ref-type="bibr" rid="bib4">Arnsten et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Floresco, 2013</xref>; <xref ref-type="bibr" rid="bib94">Robbins, 2000</xref>), we elected to do multiple stimulation sessions to boost the potential rescue effects.</p><p>We first tested whether the structural deficits in the mesofrontal dopaminergic circuit would be affected by adolescent dopamine neuron stimulation. DREADD-Gq or mCherry expression was combined with tdTomato and synaptophysin-GFP to label dopaminergic axons and boutons in the <italic>Arc</italic> mutant animals (<italic>Arc</italic>-/-;Th-Cre). After three CNO treatments in adolescence (one injection per day for 3 days in mice 5 weeks of age in their home cages), the mice were kept in their regular home cage until adulthood (8 weeks) for histological assessment (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). Although the mesofrontal dopamine axon length did not show any difference (<xref ref-type="fig" rid="fig3">Figure 3e</xref>), we found a significant increase in dopaminergic bouton density in DREADD-Gq mice compared to control animals (Ctrl: 100±4% vs. Gq: 120 ± 6%, p=0.013, <italic>t</italic>-test, t(18)=2.763, N=10 for each group; <xref ref-type="fig" rid="fig3">Figure 3f</xref>). These results suggest that adolescent dopamine neuron stimulation in <italic>Arc</italic> mutant mice led to a long-term enhancement of the connection between dopaminergic axons and M2 frontal cortical neurons, thereby ameliorating the structural deficits in these mice.</p><p>We next tested whether adolescent dopamine neuron stimulation would also lead to long-term improvement of the functional deficits in the mesofrontal circuit of <italic>Arc</italic> mutant mice. Our previous work indicated that <italic>Arc</italic> mutants have reduced frontal cortical response to VTA stimulation (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>). Using the same assay in adult mice, we found that the cortical calcium activity in response to VTA electrical stimulation was significantly enhanced in DREADD-Gq mice compared to control mCherry mice after adolescence CNO treatment (10 pulse F(1,10)=9.513, p=0.012, two-way ANOVA, N=6 mice per group, <xref ref-type="fig" rid="fig3">Figure 3g–i</xref>). These results suggest that adolescent dopamine neuron stimulation also leads to long-term improvement of the functional deficits in the mesofrontal dopaminergic circuit of <italic>Arc</italic> mutants.</p></sec><sec id="s2-4"><title>Adolescent dopamine neuron stimulation leads to restoration of coordinated frontal neuronal activity and cognition in adulthood</title><p>To further examine whether the uncoordinated frontal neural activity patterns in <italic>Arc</italic> mutant mice during the Y-maze task would be renormalized by this adolescent dopamine neuron stimulation strategy, we conducted calcium imaging using the head-mounted miniature microscope in these mice (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). We found that the coordinated activation of neurons near the maze center (<xref ref-type="fig" rid="fig4">Figure 4b</xref>) and the proportion of alternation-selective neurons (<xref ref-type="fig" rid="fig4">Figure 4c</xref>) were both significantly enhanced in <italic>Arc</italic> mutant mice that received the DREADD-Gq activation compared to the mCherry control group (p&lt;0.0001, chi-square tests, DREADD-Gq 1008 cells from 7 mice, mCherry 1286 cells from 7 mice). In contrast, the average activity of M2 neurons throughout the task period was not affected by adolescent DREADD-Gq stimulation (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1a–c</xref>). Strikingly, the DREADD-Gq-stimulated animals also showed an enhancement of behavioral alternation (p=0.010, <italic>t</italic>-test, t(12)=3.043, Ctrl: 56.8 ± 2.8%, Gq: 67.6 ± 2.2%, N=7 each group, <xref ref-type="fig" rid="fig4">Figure 4d</xref>), reaching a level comparable to that in the wild-type mice (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). Total arm entries were not affected (<xref ref-type="fig" rid="fig4">Figure 4e</xref>), suggesting no alternations in general locomotor activity. These results indicate that adult task-related functional activity in the M2 frontal cortex is restored by adolescent dopamine neuron stimulation in <italic>Arc</italic> mutant mice.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Adolescent dopamine neuron stimulation leads to restoration of coordinated frontal neuronal activity and cognition in adulthood.</title><p>(<bold>a</bold>) Diagram showing procedures for adolescent stimulation of dopamine neurons and functional imaging of frontal cortical neuron activity in adult <italic>Arc</italic>-/-;Th-Cre mice. (<bold>b</bold>) The average activity of individual frontal cortical neurons at binned positions relative to the center of Y-maze in <italic>Arc</italic> -/-; mCherry-Ctrl (1288 neurons from 7 mice) and <italic>Arc</italic>-/-; DREADD-Gq (1008 neurons from 7 mice) animals. Bottom, the proportion of neurons showing maximal activation at each maze position. This proportion reached a higher peak right before the maze center in <italic>Arc</italic>-/-; DREADD-Gq mice compared to <italic>Arc</italic>-/-; mCherry-Ctrl mice. Shaded areas indicate 95% confidence intervals. (<bold>c</bold>) The proportion of alternation-selective neurons reached a significantly higher peak right before the maze center in <italic>Arc</italic>-/-; DREADD-Gq compared to <italic>Arc</italic>-/-; mCherry-Ctrl mice. Shaded areas indicate 95% confidence intervals. (<bold>d</bold>) Y-maze alternation percentage for the animals used in the miniaturized microscope imaging experiments shows significant increase in <italic>Arc</italic>-/-;DREADD-Gq animals compared to <italic>Arc</italic>-/-; mCherry-Ctrl (*p=0.010, <italic>t</italic>-test, t(12)=3.043, N=7 mice for each group, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>e</bold>) Total arm entries are not significantly different (p=0.399, <italic>t</italic>-test, t(12)=0.875). All the error bars indicate SEM.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Adolescent dopamine neuron stimulation leads to restoration of coordinated frontal neuronal activity and cognition in adulthood.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Average activity of M2 neurons during Y-maze exploration.</title><p>(<bold>a–c</bold>) Quantifications of calcium transient amplitude (<bold>a</bold>), frequency (<bold>b</bold>), and duration (<bold>c</bold>) in <italic>Arc</italic>-/-; mCherry-Ctrl and <italic>Arc</italic>-/-;DREADD-Gq mice during Y-maze exploration show no significant difference. (<bold>a</bold>) p=0.952, <italic>t</italic>-test, t(12)=0.062; (<bold>b</bold>) p=0.985, <italic>t</italic>-test, t(12)=0.019; (<bold>c</bold>) p=0.879, <italic>t</italic>-test, t(12)=0.155. Each dot on the plot represented the cell average from one mouse. All the error bars indicate SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Efficacy requirements for adolescent dopamine neuron stimulation</title><p>To further characterize the experimental conditions that are important for the restoration of memory-guided decision-making behavior in <italic>Arc</italic> mutant mice, we examined several variables including post-stimulation test interval, stimulation duration, and the age of stimulation. First, we replicated the effects of adolescent dopamine neuron stimulation on Y-maze navigation in adulthood in another cohort of <italic>Arc</italic> mutant mice (p=0.023, <italic>t</italic>-test, t(12)=2.598, Ctrl: 59.5 ± 2.4%, Gq: 68.5 ± 2.5%, N=7 for each group) (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Furthermore, when tested only 1 day after the 3-day CNO treatment procedure (one injection per day) in adolescence, <italic>Arc</italic> mutant mice already showed an increased alternation percentage (p=0.031, <italic>t</italic>-test, t(20)=2.322, Ctrl: 55.8 ± 2.9%, Gq: 64.7 ± 2.5%, N=11 for each group) (<xref ref-type="fig" rid="fig5">Figure 5b</xref>), which is comparable to the effect observed 1 month after treatment in adult mice (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). These results suggest that the adolescent neurostimulation effect on cognitive behavioral improvement is both fast acting and long lasting.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Efficacy requirements for adolescent dopamine neuron stimulation.</title><p>(<bold>a</bold>) Top, diagram showing the base procedure for the stimulation of midbrain dopamine neurons and Y-maze testing in <italic>Arc</italic>-/-;Th-Cre mice labeled with DREADD-Gq or mCherry control viruses. Animals were injected with clozapine <italic>N</italic>-oxide (CNO) (1 mg/kg) once per day for 3 days in adolescence (5 weeks of age) and then tested in the Y-maze at adulthood (~1 month later). <italic>Arc</italic>-/-; DREADD-Gq animals show significantly higher alternation compared to <italic>Arc</italic>-/-; mCherry-Ctrl at adulthood (*p=0.023, <italic>t</italic>-test, t(12)=2.598, N=7 mice for each group, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>b</bold>) The behavioral effect at the test interval of 1 day after CNO injection. <italic>Arc</italic>-/-; DREADD-Gq animals show significantly higher alternation compared to <italic>Arc</italic>-/-; mCherry-Ctrl (*p=0.031, <italic>t</italic>-test, t(20)=2.322, N=11 mice for each group, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>c</bold>) The behavioral outcome following a long duration stimulation starting in adolescence (2 times per day, 5 days per week, for 3 weeks). These animals did not show any improvement but a declining trend in performance (p=0.12, <italic>t</italic>-test, t(9)=1.727, <italic>Arc</italic>-/-; mCherry-Ctrl N=5, <italic>Arc</italic>-/-; DREADD-Gq, N=6 mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>d</bold>) The behavioral outcome following 3 days of CNO stimulation administered in adult mice (2–3 months). These animals did not show significant difference (p=0.97, <italic>t</italic>-test, t(11)=0.037, <italic>Arc</italic>-/-;mCherry-Ctrl, N=6; <italic>Arc</italic>-/-;DREADD-Gq, N=7 mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Efficacy requirements for adolescent dopamine neuron stimulation.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Behavioral characterization of <italic>Arc</italic>-/- mice under different chemogenetic stimulation conditions.</title><p>(<bold>a</bold>) Top, diagram showing procedures for the stimulation of midbrain dopamine neurons and Y-maze testing in <italic>Arc</italic>-/-;Th-Cre mice labeled with DREADD-Gq or mCherry-Ctrl viruses. Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between mCherry-Ctrl and DREADD-Gq animals at adulthood after 3-day adolescent clozapine <italic>N</italic>-oxide (CNO) stimulation. (<bold>b</bold>) Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between mCherry-Ctrl and DREADD-Gq animals 1 day after 3-day adolescent CNO stimulation. (<bold>c</bold>) Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between mCherry-Ctrl and DREADD-Gq animals at adulthood after 3-week adolescent CNO stimulation. (<bold>d</bold>) Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between mCherry-Ctrl and DREADD-Gq animals after 3-day adult CNO stimulation. All the error bars indicate SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Second, we also tested a more intense CNO stimulation procedure involving two injections per day for 3 weeks (5 days per week) starting in adolescence. However, this strong 3-week stimulation did not enhance behavioral alternation and appeared to decrease it even further (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). These results indicate that moderate but not excessive stimulation of dopamine neurons can provide functional improvement of a deficient mesofrontal circuit, consistent with previous studies showing that an optimal level of dopamine is important for normal cognitive function (<xref ref-type="bibr" rid="bib4">Arnsten et al., 1994</xref>; <xref ref-type="bibr" rid="bib27">Floresco, 2013</xref>; <xref ref-type="bibr" rid="bib94">Robbins, 2000</xref>).</p><p>Third, we found that in adult <italic>Arc</italic> mutant mice with DREADD-Gq expression, 3-day CNO injection did not lead to any effects on Y-maze alternation behavior assayed 1 month later (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). These results indicate that adolescent, but not adult, intervention is critical for reversing this behavioral dysfunction, in agreement with the elevated adolescent structural and functional plasticity reported for the mesofrontal circuit (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>). In addition, because 3 weeks of adolescent CNO treatment or 3 days of adult CNO treatment in DREADD-Gq mice did not lead to any rescue effects, DREADD-Gq expression alone is unlikely to generate any behavior improvement. Taken together, our findings suggest that a brief stimulation of midbrain dopamine neurons in adolescence has a long-lasting effect to reverse the memory-guided decision-making deficits in <italic>Arc</italic> mutant mice, while not affecting other aspects of motor behaviors in the Y-maze (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a–d</xref>).</p></sec><sec id="s2-6"><title>Specific stimulation of adolescent frontal dopaminergic axons reverses both cognitive and psychomotor deficits</title><p>To further evaluate the impact of adolescent dopamine neuron stimulation on another frontal cortex-dependent behavioral deficit in <italic>Arc</italic> mutant mice, we subjected these mice to an amphetamine-induced hyperactivity test, which is considered an animal model for drug-induced psychomotor symptoms (<xref ref-type="bibr" rid="bib28">Forrest et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>). Classical neuropharmacological studies have shown that amphetamine-induced locomotor activity is facilitated by dopaminergic input to the nucleus accumbens but inhibited by dopaminergic input to the frontal cortex (<xref ref-type="bibr" rid="bib17">Chambers et al., 2003</xref>; <xref ref-type="bibr" rid="bib58">Le Moal and Simon, 1991</xref>; <xref ref-type="bibr" rid="bib116">Tzschentke, 2001</xref>). Consistent with a hypoactive frontal dopamine input, <italic>Arc</italic> mutant mice showed hyper-reactivity to amphetamine compared to the wild-type mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1a</xref>) as reported before (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>).</p><p>However, we found that adolescent stimulation of VTA dopamine neurons through DREADD-Gq did not reduce the hyper-reactivity to amphetamine in adult <italic>Arc</italic> mutant mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1b</xref>). Dopamine neurons in the VTA include separate neuronal populations that project to the frontal cortex and the nucleus accumbens, respectively (<xref ref-type="bibr" rid="bib12">Björklund and Dunnett, 2007</xref>; <xref ref-type="bibr" rid="bib53">Lammel et al., 2008</xref>). Our results suggest that adolescent stimulation of both populations of VTA neurons in mesofrontal and mesoaccumbens pathways, which have opposing effects on amphetamine-induced locomotor activity, result in no net change in this behavioral phenotype at adulthood.</p><p>Subsequently, we tested whether targeted stimulation of dopaminergic axons projecting to the frontal cortex would be a better strategy to reinstate memory-guided decision-making in the Y-maze task and prevent amphetamine hyper-reactivity in <italic>Arc</italic> mutant mice. Although CNO in principle could be injected directly into the frontal cortex to stimulate DREADD-Gq-labeled dopaminergic axons, we found in preliminary experiments that repeated injections (three times) in adolescent brain led to tissue deformation and damage. Therefore, we turned to a less invasive optogenetic method to enhance the activity of labeled axons using stabilized step function opsins (SSFOs), which can increase neural excitability over a 30 min time scale in response to a 2 s pulse of light (<xref ref-type="bibr" rid="bib128">Yizhar et al., 2011</xref>).</p><p>To validate the effect of SSFO-based stimulation, we expressed Cre-dependent SSFO in the midbrain dopamine neurons and stimulated their axonal projections in the M2 frontal cortex with blue light through a cranial window (<xref ref-type="fig" rid="fig6">Figure 6a</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1c–d</xref>). We monitored M2 neural activity using calcium reporter GCaMP6 before and 30 min after light activation. Similar to the DREADD-Gq-mediated activity changes in the mesofrontal circuit, frontal cortical activity was increased after light activation compared to before in SSFO animals, and this increase was significantly higher than the control EGFP animals that were also exposed to the light (p=0.001, <italic>t</italic>-test, t(8)=5.135, Ctrl: 7.5 ± 3.1%, SSFO: 46.7 ± 6.9%, N=5 each group, <xref ref-type="fig" rid="fig6">Figure 6b–c</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1e</xref>). These results indicate that light stimulation of SSFO-labeled frontal dopamine axons can enhance the activity in the mesofrontal circuit.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Specific stimulation of adolescent frontal dopaminergic axons leads to reversal of both cognitive and psychomotor deficits.</title><p>(<bold>a</bold>) Schematic for labeling dopamine neurons with stabilized step function opsin (SSFO) and two-photon imaging of frontal cortical activity with GCaMP6. (<bold>b</bold>) Example traces of spontaneous cortical activity averaged from the whole image frame in control EGFP only (blue) and SSFO (orange)-labeled animals before and 30 min after frontal cortical blue light stimulation. (<bold>c</bold>) SSFO animals show significantly higher change in cortical activity (summarized by the standard deviation of spontaneous activity traces) compared to control EGFP animals after the light activation, suggesting light activation of SSFO expressing dopamine neurons (***p=0.001, <italic>t</italic>-test, t(8)=5.135, N=5 mice for each group). Cortical activity is summarized by the standard deviation (SD) of the spontaneous activity traces. Activity change is calculated as (SD2-SD1)/SD1, where SD1 is before and SD2 after treatment. (<bold>d</bold>) Diagram showing procedures for local light activation of frontal dopaminergic projections and Y-maze testing in <italic>Arc</italic>-/-;Th-Cre mice labeled with SSFO or Ctrl-GFP viruses. Light activation was delivered in adolescence (5 weeks of age) once per day for 3 days. Animals were first tested in the Y-maze 1 day after the last light activation and then tested again in the Y-maze at adulthood, followed by an amphetamine-induced locomotion test. (<bold>e–h</bold>) SSFO-expressing animals show significantly higher alternation compared to control animals 1 day after light activation (<bold>e</bold>) (*p=0.028, <italic>t</italic>-test, t(15)=2.440, N=9 EGFP, N=8 SSFO mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05), with no difference in total entries (<bold>f</bold>). These animals also show higher alternation at adulthood (<bold>g</bold>) (*p=0.015, <italic>t</italic>-test, t(15)=2.748, EGFP N=9, SSFO N=8, both groups passed Shapiro-Wilk normality test at alpha = 0.05) with no difference in total entries (<bold>h</bold>). (<bold>i</bold>) In <italic>Arc-/-;</italic>Th-Cre mice that received adolescent frontal light stimulation, amphetamine-induced locomotion is significantly reduced at adulthood in SSFO animals compared to GFP control animals (F(1,14)=5.3, *p=0.037, two-way ANOVA, N=8 mice per group). All the error bars indicate SEM.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Specific stimulation of adolescent frontal dopaminergic axons leads to reversal of both cognitive and psychomotor deficits.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Amphetamine hyper-reactivity in <italic>Arc-/-</italic> mice and stabilized step function opsin (SSFO) expression and validation.</title><p>(<bold>a</bold>) Amphetamine-induced locomotion is significantly increased in <italic>Arc</italic>-/- animals compared to <italic>WT</italic>. (F(1,14)=9.5, *p=0.032, two-way ANOVA, N=8 mice per group). (<bold>b</bold>) Amphetamine-induced locomotion at adulthood is not significantly different between <italic>Arc-/-;</italic>Th-Cre mice labeled with mCherry-Ctrl or DREADD-Gq and treated with clozapine <italic>N</italic>-oxide (CNO) for 3 days in adolescence. All the error bars indicate SEM. (<bold>c</bold>) Confocal image of coronal midbrain section showing SSFO expression in the ventral tegmental area (VTA). Scale bar, 100 µm. (<bold>d</bold>) Confocal image of coronal cortical section showing SSFO expression in the frontal dopaminergic axons projecting from the VTA. Scale bar, 20 µm. (<bold>e</bold>) Top, example images showing standard deviation projection of in vivo two-photon calcium activity movies in the M2 frontal cortex. Bottom, example traces of spontaneous cortical activity in a representative sample of individual cells before and 30 min after light stimulation in an SSFO-labeled animal. Scale bar, 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig6-figsupp1-v1.tif"/></fig></fig-group><p>To determine whether adolescent stimulation of mesofrontal dopamine axons would be sufficient to reinstate memory-guided decision-making in <italic>Arc</italic> mutant mice, we stimulated SSFO-labeled dopamine axons in the frontal cortex once per day for 3 days in adolescence (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). When tested either 1 day after light stimulation or 1 month after in adulthood, SSFO-labeled mice showed a significant increase in the Y-maze alternation percentage compared to control EGFP animals (<xref ref-type="fig" rid="fig6">Figure 6e</xref>, 1 day after, p=0.028, <italic>t</italic>-test, t(15)=2.440, Ctrl: 58.4 ± 1.4%, SSFO: 66.5 ± 3.2%; <xref ref-type="fig" rid="fig6">Figure 6g</xref>, adulthood, p=0.015, <italic>t</italic>-test, t(15)=2.748, Ctrl: 55.5 ± 2.5%, SSFO: 66.7 ± 3.3%; N=9 for Ctrl, N=8 for SSFO). On the other hand, total arm entries were not affected (<xref ref-type="fig" rid="fig6">Figure 6f and h</xref>). These results suggest that similar to VTA dopamine neuron stimulation, projection-specific stimulation of dopaminergic axons in the frontal cortex is sufficient to restore memory-guided decision-making in <italic>Arc</italic> mutant animals.</p><p>Moreover, SSFO-mediated frontal dopamine axon stimulation in adolescence also significantly reduced the hyper-reactivity to amphetamine in adult <italic>Arc</italic> mutant mice (p=0.037, F(1,14)=5.3, two-way ANOVA, N=8 each, <xref ref-type="fig" rid="fig6">Figure 6i</xref>). Thus, adolescent stimulation of dopaminergic projections in the frontal cortex provides an effective strategy for reversing frontal dysfunctions in both memory-guided decision-making and psychostimulant reactivity.</p></sec><sec id="s2-7"><title>Adolescent dopamine neuron stimulation reverses cognitive deficits in <italic>Disc1</italic> mutant mice</title><p>Finally, we sought to determine if this adolescent neurostimulation strategy would be applicable to another genetic model with a hypoactive mesofrontal circuit. Previous studies showed that knocking down <italic>Disc1</italic> or overexpressing a dominant negative <italic>Disc1</italic> reduced mesofrontal dopaminergic innervation, dopamine release, and cognitive dysfunction (<xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>). Using a <italic>Disc1</italic> mouse model that contains a knocked-in mutation (<italic>Disc1+/-</italic>) identified from a subset of human patients (<xref ref-type="bibr" rid="bib49">Kim et al., 2021</xref>; <xref ref-type="bibr" rid="bib125">Wen et al., 2014</xref>), we first examined whether mesofrontal activity is also impaired in this model by imaging the calcium activity of M2 frontal cortex with two-photon microscopy in response to VTA stimulation (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). Our results showed a reduction of VTA-induced frontal cortical activity in <italic>Disc1</italic> mutants compared to wild-type animals (10 pulse F(1,10)=16.5, p=0.002, two-way ANOVA, N=6 mice per group, <xref ref-type="fig" rid="fig7">Figure 7b</xref>), indicating a mesofrontal hypofunction in this <italic>Disc1</italic> mutant line consistent with other <italic>Disc1</italic> models (<xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Adolescent dopamine neuron stimulation reverses cognitive deficits in <italic>Disc1</italic> mutant mice.</title><p>(<bold>a</bold>) Schematic showing the experimental setup to measure the mesofrontal circuit activity by ventral tegmental area (VTA) electrical stimulation and GCaMP6 imaging in the frontal cortex. (<bold>b</bold>) Time courses of cortical calcium signals in response to VTA stimulation in <italic>WT and Disc1+/-</italic> mice. 1, 5, or 10 pulses of electrical stimuli (50 Hz) were delivered at 20 s after the start of imaging. The cortical calcium activity at each time point is represented by the change in image fluorescence relative to the baseline image fluorescence (ΔF/F) (1 pulse F(1,10)=5.7, *p=0.038; 10 pulse F(1,10)=16.5, **p=0.002, two-way ANOVA, N=6 per group). (<bold>c</bold>) <italic>Disc1+/-</italic> mice show significant reduction in Y-maze alternation compared to <italic>WT</italic> (*p=0.044, <italic>t</italic>-test, t(18)=2.171, N=10 mice for each group, both groups passed Shapiro-Wilk normality test at alpha = 0.05). (<bold>d</bold>) <italic>Disc1+/-</italic>;Th-Cre mice with DREADD-Gq-labeled dopamine neurons show significantly higher alternation in the Y-maze at adulthood compared to mCherry-Ctrl-labeled mice after 3-day adolescent clozapine <italic>N</italic>-oxide (CNO) injections (*p=0.012, <italic>t</italic>-test, t(9)=3.139, <italic>Disc1+/-</italic>; mCherry N=5, <italic>Disc1+/-</italic>;DREADD-Gq, N=6 mice, both groups passed Shapiro-Wilk normality test at alpha = 0.05). All the error bars indicate SEM.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Adolescent dopamine neuron stimulation reverses cognitive deficits in <italic>Disc1</italic> mutant mice.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-87414-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Characterization of Y-maze behavior in <italic>Disc1+/-</italic> mice.</title><p>(<bold>a</bold>) Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between <italic>Disc1+/-</italic> and <italic>WT</italic> animals. (<bold>b</bold>) Top, diagram showing procedures for the stimulation of midbrain dopamine neurons and Y-maze testing in <italic>Disc1</italic>+/-;Th-Cre mice labeled with DREADD-Gq or mCherry-Ctrl viruses. Total entries and left-right turns (percentage of right turns shown) in the Y-maze are not significantly different between mCherry-Ctrl and DREADD-Gq animals at adulthood after 3-day adolescent clozapine <italic>N</italic>-oxide (CNO) stimulation. All the error bars indicate SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-fig7-figsupp1-v1.tif"/></fig></fig-group><p>To further determine if our <italic>Disc1</italic> mutants have deficits in memory-guided decision-making, we conducted the Y-maze test and found reduced alternation in the <italic>Disc1</italic> mutants compared to the wild-type animals (p=0.044, <italic>t</italic>-test, t(18)=2.171, <italic>WT</italic>: 66.8 ± 2.6%, <italic>Disc1+/-:</italic> 58.9 ± 2.5%, N=10 for each group; <xref ref-type="fig" rid="fig7">Figure 7c</xref>). Thus, similar to <italic>Arc</italic> mutant mice, <italic>Disc1</italic> mutant mice also exhibit a hypofunctional mesofrontal circuit and impaired cognitive function.</p><p>We then tested whether the same adolescent neurostimulation strategy used in the <italic>Arc</italic> mutant mice would also reverse the cognitive deficits in <italic>Disc1</italic> mutants. Remarkably, we found that the alternation percentage in adult <italic>Disc1</italic> animals was significantly increased after adolescent neurostimulation (p=0.012, <italic>t</italic>-test, t(9)=3.139, Ctrl: 60.7 ± 2.4%, N=5, Gq: 69.3 ± 1.5% N=6, <xref ref-type="fig" rid="fig7">Figure 7d</xref>), reaching a level similar to the wild-type mice. Other aspects of motor behaviors in the Y-maze were not affected (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1a–b</xref>). Taken together, these results suggest that adolescent dopamine neuron stimulation is effective for long-term cognitive improvement in two different genetic models of mesofrontal hypofunction.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>Fast-acting and long-lasting cognitive rescue by adolescent dopamine circuit stimulation</title><p>In this study, we have demonstrated a powerful role of adolescent dopaminergic input in inducing long-lasting circuit reorganization to reverse genetic deficits in frontal cortex function. Previous studies of dopamine function have focused on its transient neuromodulatory actions on neural dynamics or involvement in reinforcement learning (<xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib101">Schultz, 2007</xref>; <xref ref-type="bibr" rid="bib102">Seamans and Yang, 2004</xref>; <xref ref-type="bibr" rid="bib113">Tritsch and Sabatini, 2012</xref>). Here, by examining the effect of dopamine neuron stimulation over a developmental time scale, we have identified both fast acting and persistent effect of adolescent dopamine neuron activity at neuroanatomical, neurophysiological, and behavioral levels. The cognitive dysfunction present in adolescent mutant mice is readily reversed 1 day after neurostimulation and the restored performance level is maintained even 1 month later at adulthood. Interestingly, the behavioral improvement afforded by dopamine neuron stimulation is observed when the intervention was introduced transiently during the adolescence period, but not adulthood, suggesting a sensitive and limited time window for plasticity-inducing therapeutic interventions within mesofrontal dopamine circuits. These results may also stimulate future research to identify the molecular and cellular mechanisms controlling the adolescent plasticity window and explore the possibility and therapeutic potential of reopening plasticity in adulthood (<xref ref-type="bibr" rid="bib13">Caballero and Tseng, 2016</xref>; <xref ref-type="bibr" rid="bib40">Hoops and Flores, 2017</xref>; <xref ref-type="bibr" rid="bib72">Mastwal et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>).</p><p>We used both chemogentic (DREADD-Gq) and optogenetic (SSFO) methods to deliver adolescent dopamine circuit stimulation. We did not measure the precise firing patterns of the dopaminergic neurons targeted by SSFO but evaluated the effects of SSFO activation on the frontal cortex. Similar to DREADD-Gq-mediated activity changes in the mesofrontal circuit, which was blocked by D1 antagonist, we found increased frontal cortical activity post-light stimulation of frontal dopamine axons in our SSFO-treated animals. While quantitatively the firing patterns of DREADD-Gq and SSFO-activated dopaminergic neurons likely differ, qualitatively both of these manipulations lead to increased mesofrontal circuit activity and improvements in cognitive behaviors. In our previous work with wild-type adolescent mice, both wheel running and a single 10 min session of phasic optogenetic stimulation of the VTA resulted in dopaminergic bouton outgrowth in the frontal cortex (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>). Taken together, these results suggest that adolescent dopaminergic mesofrontal projections are highly responsive to neural activity changes and a variety of adolescent stimulation paradigms are sufficient to elicit lasting changes in this circuit. As dopamine’s effects often display an inverted-U dose-response curve (<xref ref-type="bibr" rid="bib27">Floresco, 2013</xref>; <xref ref-type="bibr" rid="bib118">Vijayraghavan et al., 2007</xref>), it will be interesting for future research to compare the effects of specific stimulation methods between wild-type mice and mutant mice with underlying dopamine deficiency. In addition, although we targeted dopamine neurons in our adolescent stimulation, the final behavioral outcome likely includes contributions from co-released neurotransmitters such as glutamate and non-dopaminergic neurons via network effects (<xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib75">Morales and Margolis, 2017</xref>), which will be interesting directions for future research.</p></sec><sec id="s3-2"><title>Cellular alterations in the mesofrontal circuit underlying cognitive dysfunction and rescue</title><p>Our examination across different mechanistic levels suggests a coherent picture in which increased dopamine neuron activity in adolescence leads to enhanced frontal dopaminergic innervation and cortical response to dopamine. Although many of dopamine boutons are not associated with defined postsynaptic structures, these axonal boutons and the active zones they contain are the major release sites for dopamine (<xref ref-type="bibr" rid="bib3">Arbuthnott and Wickens, 2007</xref>; <xref ref-type="bibr" rid="bib36">Goldman-Rakic et al., 1989</xref>; <xref ref-type="bibr" rid="bib65">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib111">Sulzer et al., 2016</xref>). Past studies have established a consistent association between increased dopaminergic innervation in the frontal cortex and an increase in dopamine levels (<xref ref-type="bibr" rid="bib79">Naneix et al., 2012</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>). Our previous work also found that increasing dopaminergic boutons through adolescent VTA stimulation led to prolonged frontal local field potential responses with high-frequency oscillations (<xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>), which is characteristic of increased dopaminergic signaling (<xref ref-type="bibr" rid="bib33">Gireesh and Plenz, 2008</xref>; <xref ref-type="bibr" rid="bib60">Lewis and O’Donnell, 2000</xref>; <xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib126">Wood et al., 2012</xref>). Importantly, in our quantification of the structural changes in this study, we evaluated boutons which were labeled with synaptophysin, a molecular marker indicating the presence of synaptic vesicle release machinery (<xref ref-type="bibr" rid="bib61">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib85">Oh et al., 2014</xref>). Thus, our study, taken in the context of the previous work, suggests the increased number of boutons signifying an increase in dopaminergic signaling within the mesofrontal circuit.</p><p>Previous electrophysiological studies have suggested that dopaminergic signaling can increase the signal-to-noise ratio and temporal synchrony of neural network activity during cognitive tasks (<xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Rolls et al., 2008</xref>; <xref ref-type="bibr" rid="bib117">Vander Weele et al., 2018</xref>). The neural activity deficit in <italic>Arc-/-</italic> mice is manifested in the task-coordinated neuronal activation at the decision-making point, but not in the average activity throughout the task. The uncoordinated neural activation pattern in <italic>Arc-/-</italic> mice may contribute to increased noise and decreased signal for decision-making, consistent with the hypodopaminergic cortical state in <italic>Arc-/-</italic> mice and the computational role of dopamine in enhancing the signal-to-noise ratio of neuronal ensemble activities (<xref ref-type="bibr" rid="bib66">Lohani et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Mukherjee et al., 2019</xref>; <xref ref-type="bibr" rid="bib84">O’Donnell, 2011</xref>; <xref ref-type="bibr" rid="bib95">Rolls et al., 2008</xref>; <xref ref-type="bibr" rid="bib102">Seamans and Yang, 2004</xref>; <xref ref-type="bibr" rid="bib115">Tseng and O’Donnell, 2007</xref>; <xref ref-type="bibr" rid="bib117">Vander Weele et al., 2018</xref>). After adolescent dopamine neuron stimulation, frontal dopaminergic innervation and cortical response to dopamine are enhanced, which help to restore task-coordinated neuronal activation in adult animals. As coordinated neuronal activity in frontal cortex is implicated in cognitive functions (<xref ref-type="bibr" rid="bib45">Ito et al., 2015</xref>; <xref ref-type="bibr" rid="bib105">Sigurdsson et al., 2010</xref>), the restoration of this activity may underlie the rescue of the cognitive behavioral deficit in <italic>Arc</italic> mutant mice.</p><p>It is important to note that dopamine can act on five different receptors expressed in both excitatory and inhibitory postsynaptic neurons (<xref ref-type="bibr" rid="bib83">O’Donnell, 2010</xref>; <xref ref-type="bibr" rid="bib102">Seamans and Yang, 2004</xref>; <xref ref-type="bibr" rid="bib115">Tseng and O’Donnell, 2007</xref>), and the frontal GABAergic inhibitory network undergoes major functional remodeling during adolescence (<xref ref-type="bibr" rid="bib13">Caballero and Tseng, 2016</xref>). The developmental increases in dopaminergic innervation to the frontal cortex and local GABAergic transmission are likely synergistic processes, which both contribute to the maturation of high-order cognitive functions supported by the frontal cortex (<xref ref-type="bibr" rid="bib13">Caballero and Tseng, 2016</xref>; <xref ref-type="bibr" rid="bib56">Larsen and Luna, 2018</xref>). Adolescent stimulation of dopamine neurons may interact with this maturational process to promote a network configuration conducive for synchronous and high signal-to-noise neural computation (<xref ref-type="bibr" rid="bib77">Mukherjee et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Murty et al., 2016</xref>; <xref ref-type="bibr" rid="bib90">Porter et al., 1999</xref>). The microcircuit mechanisms underlying adolescent dopamine stimulation-induced changes, particularly in the GABAergic inhibitory neurons, will be an exciting direction for future research.</p></sec><sec id="s3-3"><title>Reversal of cognitive deficits in independent genetic models</title><p>Our studies have shown that the mesofrontal dopamine circuit is a common target disrupted by mutations in <italic>Arc</italic> and <italic>Disc1</italic>. The initial motivation of this study was to test if adolescent dopamine stimulation can rescue the deficits in the mesofrontal dopaminergic circuit and cognitive function of <italic>Arc-/-</italic> mice, which were identified in our previous studies (<xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>). We first conducted multiple levels of analyses including viral tracing, in vivo calcium imaging, and behavioral tests to establish the coherent impacts of adolescent dopamine neuron stimulation on circuits and behaviors. We then examined a range of stimulation protocols to assess the efficacy requirements for cognitive improvement, which is our primary goal. Finally, we included <italic>Disc1</italic> mice in our study to test if adolescent dopamine stimulation can also reverse the cognitive deficit in another genetic model for mesofrontal dopamine deficiency. By demonstrating a similar cognitive recuse effect of adolescent VTA stimulation in an independent mouse model, this study provides a foundation for future research to compare the detailed cellular mechanisms that underlie the functional rescue in different genetic models.</p><p>Arc and Disc1 have different protein interaction partners and function in distinct molecular pathways. Arc is best understood for its role in regulating the trafficking of excitatory neurotransmitter receptors at synapses, whereas Disc1 has been shown to act as a scaffold protein to interact with multiple cytoskeletal proteins and synaptic molecules (<xref ref-type="bibr" rid="bib25">El-Boustani et al., 2018</xref>; <xref ref-type="bibr" rid="bib44">Ishizuka et al., 2006</xref>; <xref ref-type="bibr" rid="bib50">Kirov et al., 2012</xref>; <xref ref-type="bibr" rid="bib129">Zhang et al., 2015</xref>). Dopamine-related deficits have been reported in multiple <italic>Arc</italic> and <italic>Disc1</italic> mutant lines or direct knockdown of these molecules (<xref ref-type="bibr" rid="bib31">Gao et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>; <xref ref-type="bibr" rid="bib82">Niwa et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Niwa et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Penrod et al., 2019</xref>; <xref ref-type="bibr" rid="bib100">Salery et al., 2017</xref>), but the exact molecular mechanisms underlying these deficits and the varying severity in different models remain to be elucidated in future studies. Considering the widely reported roles of Arc and Disc1 in regulating activity-dependent synaptic plasticity (<xref ref-type="bibr" rid="bib104">Shepherd and Bear, 2011</xref>; <xref ref-type="bibr" rid="bib114">Tropea et al., 2018</xref>), mutations in these genes may compromise activity-dependent maturation of the mesofrontal dopaminergic circuit. In the two mouse lines we tested, both <italic>Arc</italic> and <italic>Disc1</italic> mutations lead to a hypoactive mesofrontal circuit and deficits in memory-guided decision-making behaviors. Our study demonstrates that the cognitive behavioral phenotypes arising from distinct genetic origins can be effectively rescued by the same neurostimulation strategy targeting a convergent mesofrontal circuit phenotype during a critical adolescent window.</p></sec><sec id="s3-4"><title>Reversal of both cognitive and psychomotor deficits by targeting frontal dopamine projections</title><p>Our work reveals a specific circuit target for long-lasting restoration of cognitive control functions. Dopamine neurons projecting to the frontal cortex are located in the VTA but are distinct from those projecting to the nucleus accumbens (<xref ref-type="bibr" rid="bib12">Björklund and Dunnett, 2007</xref>; <xref ref-type="bibr" rid="bib53">Lammel et al., 2008</xref>). Our initial chemogenetic neuromodulation strategies targeted most of the dopamine neurons in the VTA. While changes in the mesofrontal dopamine circuit were clearly induced, we cannot rule out other potential changes in the brain that might be also induced by such a targeting strategy and result in the lack of net effect related to amphetamine reactivity. The more refined optogenetic (SSFO) neurostimulation method allowed us to specifically target the dopaminergic axons projecting to the frontal cortex. Enhancing their activity transiently in adolescence is sufficient to not only restore memory-guided decision-making in the Y-maze task but also prevent hyper-reactivity to amphetamine. Thus, the mesofrontal dopaminergic circuit may provide an important therapeutic target to restore both cognitive control functions and prevent psychomotor symptoms.</p><p>We did not examine the degree of bouton growth in the SSFO cohort, which is a limitation of this study. Accurate quantification of dopamine boutons requires the co-injection of another AAV vector encoding synaptophysin-GFP to label the boutons. Because we used light to directly stimulate SSFO-labeled dopaminergic axons in the frontal cortex, we were concerned that co-injecting another AAV vector may dilute SSFO labeling of axons and reduce the efficacy of optogenetic stimulation. Given the behavioral benefits we observed, we would expect an increase in bouton density after optogenetic stimulation. A systematic optimization of viral co-labeling and optogenetic stimulation protocols will facilitate examination of the impact of SSFO stimulation at the structural level in future studies.</p><p>This study focused on the M2 region of the frontal cortex because it is functionally required for memory-guided Y-maze navigation, generates behavioral choice-related neural signals during spatial navigation, and is optically most accessible. The medial prefrontal regions (anterior cingulate, prelimbic, and infralimbic) ventral to M2 also receive dense dopaminergic innervation and can act in concert with M2 in decision-making (<xref ref-type="bibr" rid="bib7">Barthas and Kwan, 2017</xref>; <xref ref-type="bibr" rid="bib110">Sul et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Sul et al., 2010</xref>). As dopaminergic innervations to the frontal cortical regions progress in a ventral-to-dorsal direction during development (<xref ref-type="bibr" rid="bib40">Hoops and Flores, 2017</xref>; <xref ref-type="bibr" rid="bib47">Kalsbeek et al., 1988</xref>), how the changes induced by adolescent dopamine stimulation may proceed spatial-temporally across different frontal subregions requires more extensive investigation in the future.</p><p>In conclusion, our results suggest that adolescent frontal dopaminergic projections may provide an effective target to achieve fast-acting and enduring improvement of cognitive function while avoiding psychotic exacerbation, which has been a long-standing challenge for neuroscience and psychiatric research (<xref ref-type="bibr" rid="bib35">Goff et al., 2011</xref>; <xref ref-type="bibr" rid="bib38">Green, 2007</xref>; <xref ref-type="bibr" rid="bib43">Insel, 2010</xref>; <xref ref-type="bibr" rid="bib74">Miyamoto et al., 2005</xref>). Developmentally guided and circuit-based intervention strategies that use clinical brain stimulation, local pharmacological application, or behavioral training methods (<xref ref-type="bibr" rid="bib19">Dahl et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Larsen and Luna, 2018</xref>; <xref ref-type="bibr" rid="bib67">Lüscher et al., 2015</xref>; <xref ref-type="bibr" rid="bib77">Mukherjee et al., 2019</xref>) to engage the adolescent mesofrontal dopamine circuit may offer new routes to treat cognitive and behavior control disorders.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Arc</italic></td><td align="left" valign="bottom">NCBI Gene ID</td><td align="char" char="." valign="bottom">11838</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Disc1</italic></td><td align="left" valign="bottom">NCBI Gene ID</td><td align="char" char="." valign="bottom">244667</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6</td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="char" char="." valign="bottom">000664</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Arc-/-</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="char" char="." valign="bottom">007662</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Disc1+/-</italic></td><td align="left" valign="bottom">The Jackson Laboratory</td><td align="char" char="." valign="bottom">036106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">Th-Cre</td><td align="left" valign="bottom">MMRRC</td><td align="char" char="." valign="bottom">031029</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV2/9 -Syn-GCaMP6s</td><td align="left" valign="bottom">Boston Children’s Hospital Viral Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV8-CaMKIIa-hM4D(Gi)-mCherry</td><td align="left" valign="bottom">UNC Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV8-Syn-mCherry</td><td align="left" valign="bottom">Boston Children’s Hospital Viral Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV2/9-phSyn1(S)-Flex-tdTomato-T2A-SynEGFP-WPRE</td><td align="left" valign="bottom">Boston Children’s Hospital Viral Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV9.CAG.Flex.tdTomato.WPRE.bGH</td><td align="left" valign="bottom">Penn Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">pAAV8-hSyn-DIO-hM3D(Gq)-mCherry</td><td align="left" valign="bottom">UNC Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">pAAV8-hSyn-DIO-mCherry</td><td align="left" valign="bottom">UNC Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV1.Syn.Flex.GCaMP6s.WPRE.SV40</td><td align="left" valign="bottom">Penn Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">pAAV9-EF1a-DIO-hChR2(C128S/D156A)-EYFP</td><td align="left" valign="bottom">Penn Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (Adeno-associated Virus)</td><td align="left" valign="bottom">AAV2/1.CAG.FLEX.EGFP.WPRE.bGH</td><td align="left" valign="bottom">Penn Vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">d-Amphetamine</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">A5880</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Clozapine <italic>N</italic>-oxide</td><td align="left" valign="bottom">Enzo Life Sciences</td><td align="left" valign="bottom">BML-NS105-0005</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">SCH23390</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">D054</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Matlab</td><td align="left" valign="bottom">MathWorks</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Mosaic</td><td align="left" valign="bottom">Inscopix</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ImageJ</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prizm</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental model and subject details</title><p><italic>Arc</italic>-/- (<xref ref-type="bibr" rid="bib121">Wang et al., 2006</xref>), <italic>Disc1+/-</italic> (<xref ref-type="bibr" rid="bib49">Kim et al., 2021</xref>)<italic>,</italic> and hemizygote Th-Cre transgenic (<xref ref-type="bibr" rid="bib37">Gong et al., 2007</xref>) mice in the C57BL/6 strain were used in this study. <italic>Arc</italic>-/-;Th-Cre and <italic>Disc1+/-</italic>;Th-Cre lines were generated by in-house breeding. Mice were normally housed in groups of two to five animals. Estrous cycles are known to affect frontal dopamine activity (<xref ref-type="bibr" rid="bib8">Becker and Cha, 1989</xref>; <xref ref-type="bibr" rid="bib22">Dazzi et al., 2007</xref>) and the experiments in this study are limited to male mice of appropriate genotypes. It will be important for future studies to examine female mice at various estrous stages. Litter mates were randomly assigned into control or experimental groups. Behavioral tests were run blinded to the experimental conditions. Experimental protocols were approved by the National Institute of Mental Health Animal Care and Use Committee and the University Committee on Animal Resources (UCAR) at the University of Rochester Medical Center.</p></sec><sec id="s4-2"><title>Method details</title><sec id="s4-2-1"><title>Spontaneous alternation in the Y-maze</title><p>A three-arm plexiglass Y-maze (45 cm length × 8 cm width × 12 cm height for each arm) was used to test spontaneous alternation. Animals were brought into the testing room at least 30 min prior to the start of the session to acclimate to the room. Room lights were dimmed to ~10–15 lux. Animals were placed in the start arm facing away from the center. Recording of the session was started when the animal started to move toward the center and the animal was allowed to freely explore the Y-maze for 8 min. The Y-maze was cleaned with 70% ethanol between animals.</p><p>Videos of the sessions were analyzed blindly offline. Arms were identified as A, B, C. Starting from the start arm, entry into each arm was recorded as a sequence of arm letters. Entry was recorded if all four paws of the animal entered the arm. The number of alternating entries (triplet sequences with non-repeating letters, e.g. ABC) and total entries (total number of letters) were counted. Alternation percentage was calculated as: (total alternating entries/(total entries-2)) × 100.</p></sec><sec id="s4-2-2"><title>Amphetamine-induced locomotion</title><p>An animal was placed in an open field arena (50 cm × 50 cm × 25 cm) and monitored by video camera for 10 min. After that, d-amphetamine (1.5 mg/kg) was injected (i.p.), and the animal was monitored by video camera for another 60 min in the arena. Locomotion was automatically tracked using the animal’s body position by the Limelight video tracking system (Actimetrics-Coulbourn Instruments).</p></sec><sec id="s4-2-3"><title>Calcium imaging with head-mounted miniature microscope</title><p><italic>WT</italic> and <italic>Arc</italic>-/- animals were prepared for surgery following previous published procedures (<xref ref-type="bibr" rid="bib15">Cao et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Li et al., 2017</xref>). Mice were anesthetized with Avertin (1.5% solution given at 0.01 ml/g, i.p.) and treated with dexamethasone (0.2 mg/kg, s.c.) and carprofen (5 mg/kg, s.c.) to prevent brain swelling and inflammation. A piece of skull (3.5 mm in diameter) in the frontal cortex was removed after high-speed dental drilling. AAV2/9 -Syn-GCaMP6s (3–5×10<sup>12</sup> copies/ml, 0.6 μl per animal) was infused into M2 frontal cortex (Bregma, AP1.7, ML0.8) from the pial surface using a micro-syringe pump (<xref ref-type="bibr" rid="bib63">Li et al., 2017</xref>). A 3 mm coverslip was used to seal the cranial window and the exposed scalp was sutured after cranial window surgery. 7–10 days later, the baseplate of a miniaturized integrated fluorescent microscope (Inscopix) was fixed on top of the coverslip. Animals were habituated to the attachment of the microscope (20 min per day for 4 days), then imaged during the spontaneous Y-maze alternation task.</p><p>Calcium imaging was performed in freely moving mice using the head-attached microscope (LED power: 0.6–1.0 mW; camera resolution: 1440×1080 pixels). Images were acquired at 30 Hz using nVista 2.0 (Inscopix). At the beginning of each imaging session, the protective cap of the previously implanted baseplate was removed, and the microscope was attached. The imaging field of view was 900 μm×600 μm at 0.65 μm/pixel resolution and the imaging depth was selected by adjusting the focus of the microscope until clear neuronal signals were observed in online ΔF/F calcium video. The focal plane was 150–250 μm below the lens. Mouse behavior was recorded with a video camera (Limelight), which was synchronized with calcium imaging using the trigger-out signal from nVista.</p><p>Calcium imaging videos were analyzed by using Mosaic software (Inscopix) and custom-written scripts in Matlab following published algorithms (<xref ref-type="bibr" rid="bib42">Hyvärinen and Oja, 2000</xref>; <xref ref-type="bibr" rid="bib76">Mukamel et al., 2009</xref>). Raw videos were first down-sampled by fourfold along spatial dimensions to reduce file size and noise. The mean fluorescence intensity of each pixel during a recording session (8 min) was calculated as F0 and changes in pixel intensity at time t were expressed as (Ft - F0)/F0 or ΔF/F0. To extract active neuronal signals, principal component and independent component analysis was applied to the spatial-temporal data matrices of ΔF/F0 using CellSort and fastICA toolboxes (these toolboxes are freely downloadable from Matlab central). This analysis decomposes a spatiotemporal data matrix into independent components based on the skewness of data distribution. Each component has a characteristic spatial filter over the imaged area and a corresponding temporal signal during the imaging period. The spatial filter and the temporal signal of each component were graphically displayed and inspected by human observers who were blind to the experimental conditions of each video. If the spatial filter for a component overlapped with the dark shadows casted by blood vessels in the F0 image, this component was likely contributed by blood flow and was therefore rejected. In addition, since calcium signals show characteristic fast-rising and slow-decaying time course (<xref ref-type="bibr" rid="bib18">Chen et al., 2013</xref>), the temporal skewness of calcium signals is expected to be positive and those components with skewness less than 1 were rejected (<xref ref-type="bibr" rid="bib76">Mukamel et al., 2009</xref>). For each selected component, the corresponding temporal signal of each neuron was calculated from the ΔF/F0 video by subtracting the median value of the background area (in a doughnut shape surrounding the target cell) from the average value of the cell soma area.</p><p>To identify periods of increased neuronal activity, we searched for the rising phase of each calcium event (peak ΔF/F0 &gt;3 standard deviation of baseline fluctuation), which has been shown closely associated with neuronal spiking activities (<xref ref-type="bibr" rid="bib18">Chen et al., 2013</xref>). The start of this rising phase is detected when the first derivative of ΔF/F0 (calculated in 200 ms moving window) rises above 0 and continues to increase above 5 standard deviation of baseline fluctuation, and the end of this rising phase is detected when the first derivative of ΔF/F0 falls below 0. The magnitude of the calcium event is calculated as the ΔF/F0 difference between the start and end of the event.</p><p>To measure an animal’s movement in the Y-maze, the center of body mass was tracked in background-subtracted behavioral video using custom-written Matlab scripts. The animal’s movement in Y-maze was divided into trials. Each trial began when the animal started moving away from the terminal of one arm and ended after it stopped at the terminal of another arm. To analyze neuronal activity changes along the Y-maze track, the animal’s position in each trial was mapped into 20 equally divided location bins from one terminal to another. The calcium activity for each neuron in each trial was then averaged according to the binned position. To compare neuronal activity under different experimental conditions, the spatially averaged activities were further averaged across trials. The resulting traces from all detected cortical neurons were sorted based on their peak activation time and displayed in temporal raster plots. The proportion of neurons that showed maximal activity at each binned location was then calculated. To measure the alternation selectivity of neurons, neuronal activity difference between alternating and non-alternating trials were calculated at each track position. If the difference at a particular position is higher than 2 standard deviations of the differences at all other positions, the activity was determined as alternation-selective at the designated position.</p></sec><sec id="s4-2-4"><title>Frontal cortex inhibition and Y-maze testing</title><p>Animals were prepared for surgery following previous published procedures (<xref ref-type="bibr" rid="bib15">Cao et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Cao et al., 2013</xref>; <xref ref-type="bibr" rid="bib63">Li et al., 2017</xref>). Mice were anesthetized with Avertin (1.5% solution given at 0.01 ml/g, i.p.). 0.7 μl of AAV8-CaMKIIa-hM4D(Gi)-mCherry (4×10<sup>12</sup> copies/ml, UNC Vector Core) or AAV8-Syn-mCherry (3×10<sup>12</sup> copies/ml, Boston Children’s Hospital Viral Core) was injected into the M2 frontal cortex (from bregma: AP 1.7, ML 0.5, DV 1.0 mm) bilaterally. After 2 weeks, mCherry-expressing controls were injected with CNO (3 mg/kg) and Gi-expressing animals were injected with either CNO (3 mg/kg) or 0.9% saline control. Animals were run in the Y-maze 1 hr after the injections. After behavioral testing, animals were perfused and M2 frontal cortical expression was confirmed by confocal microscopy of brain sections.</p></sec><sec id="s4-2-5"><title>Labeling and imaging of VTA dopaminergic neurons and projections to the frontal cortex</title><p>AAV2/9-phSyn1(S)-Flex-tdTomato-T2A-SynEGFP-WPRE (4×10<sup>13</sup> copies/ml, Boston Children’s Hospital Viral Core, 0.5 µl) and AAV9.CAG.Flex.tdTomato.WPRE.bGH (9×10<sup>12</sup> copies/ml, Penn Vector Core, 0.3 µl) were mixed together and injected into the right hemisphere of the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4mm) of <italic>Arc</italic>+/+;Th-Cre and <italic>Arc</italic>-/-;Th-Cre animals. Animals were allowed to recover for ~2 weeks. Animals were then perfused with 0.9% saline followed by 4% paraformaldehyde (PFA) and post-fixed overnight at 4°C. Coronal 100 µm thick sections in the frontal cortical and midbrain regions were prepared with a sliding microtome. Three sections in the frontal cortical region (AP 1.6, 1.8, and 2.0; 25× lens, 10 µm Z-stack, 10 stacks per section) and five sections in the midbrain region (AP −2.9, –3.1, −3.3, –3.5, and –3.7; 10× lens, single-frame images) were imaged in both the green and red channels using confocal microscopy (Olympus FV1000). For the frontal cortex, each image stack was maximum projected, and the 10 stacks were stitched together for each section. Animals that did not show VTA labeling were excluded from further analysis.</p><p>Image analysis was carried out using custom Matlab scripts. For boutons and axons, an ROI for the M2 region was drawn in each section using the mouse brain atlas (Paxinos) as reference, and boutons and axons were identified within this region. SypGFP-labeled green channel images were used for bouton quantification. Boutons were detected automatically using a Laplacian filter and thresholded at 5 standard deviations above background. tdTomato-labeled red channel images were used for the axon quantification. Axons were detected automatically using a Hessian filter, thresholded at 2 standard deviations above background, and skeletonized. For the midbrain sections, cells were detected automatically using a Laplacian filter and thresholded at 2 standard deviations above background. For each animal, the bouton density was normalized by the total axon length, and the total axon length was normalized by the total number of tdTomato-labeled midbrain dopamine cells.</p></sec><sec id="s4-2-6"><title>Expression of DREADD-Gq in midbrain dopamine neurons and validation of CNO-induced mesofrontal activation</title><p>0.7 µl of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry (6×10<sup>12</sup> copies/ml, UNC Vector Core) or pAAV8-hSyn-DIO-mCherry (3×10<sup>12</sup> copies/ml, UNC Vector Core) was injected into the right hemisphere of the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4 mm) and 0.7 µl of AAV1.Syn.Flex.GCaMP6s.WPRE.SV40 (2×10<sup>12</sup> copies /ml, Penn Vector Core) was injected into the right hemisphere of the frontal cortex (from bregma: AP 1.7, ML 0.7, DV 0.4 mm) of Th-Cre adult animals.</p><p>After ~2 weeks, a cranial window was opened above the AAV-GCaMP6 injected region in the frontal cortex (from Bregma: AP 1.0–3.0 mm, ML 0.3–1.3 mm, covering the M2 region) in animals anesthetized with isofluorane (~1.5%). The cranial window was filled with silicone gel, covered with a glass coverslip, and sealed with dental cement. A head plate was glued on the skull for fixation during imaging. The animals were then taken off the anesthesia and allowed to recover for ~1 hr before imaging. A two-photon microscope (FV1000, Olympus) was used to image the brain under the cranial window (excitation laser: 900 nm) using a 20× water immersion lens (NA 0.95) in the head fixed awake animal. Animals were imaged before and 1 hr after CNO (1 mg/kg, i.p.) injection. After imaging, animals were perfused, and DREADD-Gq expression was confirmed in the midbrain regions. Animals that did not show VTA labeling were excluded from further analysis.</p><p>Images were analyzed using NIH ImageJ. Two 2 min movies of spontaneous activity before and after CNO were analyzed. The mean pixel intensity in each image frame of the movie was calculated as Ft. Baseline fluorescence (<bold>F0</bold>) was defined as the average of the fluorescent signals (Ft) in the time series. Changes in calcium signals (ΔF/F) are calculated as (Ft-F0)/F0. The standard deviation of the (ΔF/F) was used as a quantitative measure of overall cortical activity.</p></sec><sec id="s4-2-7"><title>CNO stimulation of DREADD-Gq in midbrain dopamine neurons and behavior testing</title><p>Animals were prepared for surgery as above. 0.7 µl of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry or pAAV8-hSyn-DIO-mCherry was bilaterally injected into the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4mm) of <italic>Arc</italic>-/-;Th-Cre or <italic>Disc1+/-</italic>;Th-Cre animals within postnatal days P21–P25. CNO (1 mg/kg, i.p.) was injected 1 time per day for 3 days into the animals within postnatal days P35–P42. For 1-day-after tests, animals were tested on the Y-maze 1 day after the last injection day. For adulthood tests, animals were tested at 2–3 month age on the Y-maze. Some of the adult animals were also tested for amphetamine-induced locomotion as described above. After behavior testing, animals were perfused, and DREADD-Gq expression was confirmed in the ventral midbrain region. Animals that did not show VTA labeling were excluded from further analysis.</p></sec><sec id="s4-2-8"><title>CNO stimulation of DREADD-Gq in midbrain dopamine neurons and in vivo imaging of cortical activity</title><p>Animals were prepared for surgery as described above. 0.7 µl of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry or pAAV8-hSyn-DIO-mCherry was bilaterally injected into the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4mm) of <italic>Arc</italic>-/-;Th-Cre animals within postnatal days P21–P25. CNO (1 mg/kg, i.p.) was injected 1 time daily for 3 days into the animals for activation within postnatal days P35–P42. At adulthood, GCaMP6 labeling, cranial window opening, and imaging during Y-maze were carried out as described above. After an interval of at least 1 day after miniscope imaging, animals were used for VTA electrical stimulation coupled with in vivo two-photon imaging. A bipolar stimulation electrode was placed into the VTA (from bregma: AP –3.2, ML 0.5, and DV 4.5 mm) and glued in place in animals anesthetized with isofluorane (~1.5%). A head plate was also glued on to the skull. The animals were then taken off the anesthesia and allowed to recover for ~1 hr before imaging. Time series images lasting ~40 s (115 frames at 0.351 s/frame) were taken for each stimulus train, with the VTA stimulus delivered at 20 s after the start of imaging. Image analysis was carried out as described above. Baseline fluorescence (F0) was defined as the average of the fluorescent signals (Ft) in the first 15 s of the time series. Changes in calcium signals (ΔF/F) are calculated as (Ft-F0)/F0. After imaging, animals were perfused, and DREADD-Gq expression was confirmed in the midbrain regions. Animals that did not show VTA labeling were excluded from further analysis.</p></sec><sec id="s4-2-9"><title>CNO stimulation of DREADD-Gq in midbrain dopamine neurons and imaging of mesofrontal axons and boutons</title><p>Animals were prepared for surgery as described above. A mixture of 0.4 µl of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry or pAAV8-hSyn-DIO-mCherry 0.5 µl AAV2/9-phSyn1(S)-Flex-tdTomato-T2A-SynEGFP-WPRE and 0.3 µl AAV9.CAG.Flex.tdTomato.WPRE.bGH was injected into the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4 mm) of <italic>Arc</italic>-/-;Th-Cre animals within postnatal days P21–P25. The procedure was later modified with a 0.6 µl of pAAV8-hSyn-DIO-hM3D(Gq)-mCherry or pAAV8-hSyn-DIO-mCherry first and then immediately followed by an injection of a mixture of 0.5 µl AAV2/9-phSyn1(S)-Flex-tdTomato-T2A-SynEGFP-WPRE and 0.3 µl AAV9.CAG.Flex.tdTomato.WPRE.bGH. 12 animals from the first procedure and 8 animals from the latter procedure were pooled together for the analysis. CNO (1 mg/kg, i.p.) was injected one time daily for 3 days into the animals within postnatal days P35–P42. At adulthood, animals were then perfused with 0.9% saline followed by 4% PFA and post-fixed overnight at 4°C. Coronal 100 µm thick sections in the frontal cortical and midbrain regions were prepared with a sliding microtome. Three sections in the frontal cortical region (AP 1.6, 1.8, and 2.0) and five sections in the midbrain region (AP −2.9, –3.1, −3.3, –3.5, and –3.7) were imaged in both the green and red channels using confocal microscopy. Image analysis was carried out as described above.</p></sec><sec id="s4-2-10"><title>SSFO expression in midbrain dopamine neurons and validation of cortical light activation</title><p>0.7 µl of pAAV9-EF1a-DIO-hChR2(C128S/D156A)-EYFP (titer 5×10<sup>13</sup> copies/ml diluted 1:20 in PBS, Penn Vector Core) or AAV2/1.CAG.FLEX.EGFP.WPRE.bGH (titer 8×10<sup>12</sup> copies/ml, Penn Vector Core) was injected into the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4 mm) and 0.7 µl of AAV1.Syn.Flex.GCaMP6s.WPRE.SV40 (titer 8×10<sup>12</sup>copies/ml, Penn Vector Core) was injected into the frontal cortex (from bregma: AP 1.7, ML 0.7, DV 0.4 mm) of Th-Cre adult animals.</p><p>After ~2 weeks, cranial window (from Bregma: AP 1.0–2.5 mm, ML 1 mm) opening and two-photon imaging was carried out as described above. Animals were imaged before and 30 min after light activation with an optical fiber (200 μm in diameter, Thor Labs) connected to a 473 nm solid-state laser diode (CrystaLaser) with ~10 mW output from the fiber. Three spots separated by around 200 µm anterior-posterior in the center of the window were activated with a 2 s light pulse for each spot. After imaging, animals were perfused, and SSFO expression was confirmed in the midbrain regions. Images were analyzed as described above. Three min times series images of spontaneous activity before and after CNO were analyzed. Baseline fluorescence (F0) was defined as the average of the fluorescent signals (Ft) in the time series. The standard deviation of the (ΔF/F) was used as a quantitative measure of overall cortical activity.</p></sec><sec id="s4-2-11"><title>Light activation of SSFO in frontal dopaminergic axons and behavioral testing</title><p>0.7 µl of pAAV9-EF1a-DIO hChR2(C128S/D156A)-EYFP or AAV2/1.CAG.FLEX. EGFP.WPRE.bGH was bilaterally injected into the midbrain region (from bregma: AP –3.2, ML 0.5, DV 4.4mm) of <italic>Arc</italic>-/-;Th-Cre animals within postnatal days P21–P25. Around postnatal days P35–P42, a cranial window was opened in above the frontal cortex (from Bregma: AP 1.0–2.5 mm, ML 1 mm across both sides of the midline) in animals anesthetized with isofluorane (~1.5%). The cranial window was filled with silicone gel, covered with a glass coverslip, and sealed with dental cement. A head bar was glued on the skull for fixation during light activation. Animals were allowed to wake and recover for at least 2 hr. Animals were then head fixed and an optical fiber (200 μm in diameter, Thor Labs) connected to a 473 nm solid-state laser diode (CrystaLaser) with ~10 mW output from the fiber was used to deliver 2 s light pulses to the frontal cortex. Three spots separated by around 200 µm anterior-posterior in the center of the window were activated in each hemisphere. The light activation was repeated for 2 more days. For 1-day-after tests, animals were tested in the Y-maze 1 day after the last injection day. For adulthood tests, animals of 2–3 month age were first tested in the Y-maze, then tested for amphetamine-induced locomotion as described above. After behavior testing, animals were perfused, and SSFO expression was confirmed in the midbrain regions. Animals that did not show VTA labeling were excluded from further analysis.</p></sec></sec><sec id="s4-3"><title>Quantification and statistical analysis</title><p>Statistical analyses were performed in Prism 9 or Matlab. No statistical methods were used to predetermine sample size. Sample sizes were chosen based on previous studies using similar techniques to determine biological effects (<xref ref-type="bibr" rid="bib64">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Managò et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Mastwal et al., 2014</xref>; <xref ref-type="bibr" rid="bib122">Wang et al., 2017</xref>). Statistical differences between the means of two groups were evaluated with two-tailed <italic>t</italic>-test and normality was confirmed with Shapiro-Wilk test. Statistical differences between the means of multiple groups were determined using ANOVA. Statistical differences between two proportions were evaluated with chi-squared test.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Experimental protocols were approved by the National Institute of Mental Health Animal Care and Use Committee (Protocol Number: GCP-01) and the University Committee on Animal Resources (UCAR) at the University of Rochester Medical Center (Protocol Number: 102193). All surgery was performed under isoflurane anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-87414-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting file. Source data files have been provided containing the numerical data used to generate the figures.</p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Drs. Y Chudasama, F Wang, Z He for critical reading of the manuscript and J Pulizzi for technical assistance. This work was supported by grants from National Institutes of Health (ZIAMH002897 and R01MH127737 to KHW, F32MH124298 to RS, U19MH106434 and R35NS116843 to HS, and R35NS097370 to GLM) and Del Monte Institute for Neuroscience at University of Rochester (to KHW).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>GM</given-names></name><name><surname>Rogan</surname><given-names>SC</given-names></name><name><surname>Abbas</surname><given-names>AI</given-names></name><name><surname>Armbruster</surname><given-names>BN</given-names></name><name><surname>Pei</surname><given-names>Y</given-names></name><name><surname>Allen</surname><given-names>JA</given-names></name><name><surname>Nonneman</surname><given-names>RJ</given-names></name><name><surname>Hartmann</surname><given-names>J</given-names></name><name><surname>Moy</surname><given-names>SS</given-names></name><name><surname>Nicolelis</surname><given-names>MA</given-names></name><name><surname>McNamara</surname><given-names>JO</given-names></name><name><surname>Roth</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors</article-title><source>Neuron</source><volume>63</volume><fpage>27</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.06.014</pub-id><pub-id pub-id-type="pmid">19607790</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aransay</surname><given-names>A</given-names></name><name><surname>Rodríguez-López</surname><given-names>C</given-names></name><name><surname>García-Amado</surname><given-names>M</given-names></name><name><surname>Clascá</surname><given-names>F</given-names></name><name><surname>Prensa</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-range projection neurons of the mouse ventral tegmental area: a single-cell axon tracing analysis</article-title><source>Frontiers in Neuroanatomy</source><volume>9</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2015.00059</pub-id><pub-id pub-id-type="pmid">26042000</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbuthnott</surname><given-names>GW</given-names></name><name><surname>Wickens</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Space, time and dopamine</article-title><source>Trends in Neurosciences</source><volume>30</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2006.12.003</pub-id><pub-id pub-id-type="pmid">17173981</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name><name><surname>Cai</surname><given-names>JX</given-names></name><name><surname>Murphy</surname><given-names>BL</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys</article-title><source>Psychopharmacology</source><volume>116</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1007/BF02245056</pub-id><pub-id pub-id-type="pmid">7862943</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Catecholamine regulation of the prefrontal cortex</article-title><source>Journal of Psychopharmacology</source><volume>11</volume><fpage>151</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1177/026988119701100208</pub-id><pub-id pub-id-type="pmid">9208378</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbui</surname><given-names>C</given-names></name><name><surname>Signoretti</surname><given-names>A</given-names></name><name><surname>Mulè</surname><given-names>S</given-names></name><name><surname>Boso</surname><given-names>M</given-names></name><name><surname>Cipriani</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Does the addition of a second antipsychotic drug improve clozapine treatment?</article-title><source>Schizophrenia Bulletin</source><volume>35</volume><fpage>458</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbn030</pub-id><pub-id pub-id-type="pmid">18436527</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barthas</surname><given-names>F</given-names></name><name><surname>Kwan</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Secondary motor cortex: Where “sensory” meets “motor” in the rodent frontal cortex</article-title><source>Trends in Neurosciences</source><volume>40</volume><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2016.11.006</pub-id><pub-id pub-id-type="pmid">28012708</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>JB</given-names></name><name><surname>Cha</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis</article-title><source>Behavioural Brain Research</source><volume>35</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/s0166-4328(89)80112-3</pub-id><pub-id pub-id-type="pmid">2818831</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beier</surname><given-names>KT</given-names></name><name><surname>Steinberg</surname><given-names>EE</given-names></name><name><surname>DeLoach</surname><given-names>KE</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Schwarz</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>XJ</given-names></name><name><surname>Kremer</surname><given-names>EJ</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping</article-title><source>Cell</source><volume>162</volume><fpage>622</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.015</pub-id><pub-id pub-id-type="pmid">26232228</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belforte</surname><given-names>JE</given-names></name><name><surname>Zsiros</surname><given-names>V</given-names></name><name><surname>Sklar</surname><given-names>ER</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Quinlan</surname><given-names>EM</given-names></name><name><surname>Nakazawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1038/nn.2447</pub-id><pub-id pub-id-type="pmid">19915563</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berger</surname><given-names>B</given-names></name><name><surname>Gaspar</surname><given-names>P</given-names></name><name><surname>Verney</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates</article-title><source>Trends in Neurosciences</source><volume>14</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/0166-2236(91)90179-x</pub-id><pub-id pub-id-type="pmid">1709528</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björklund</surname><given-names>A</given-names></name><name><surname>Dunnett</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dopamine neuron systems in the brain: an update</article-title><source>Trends in Neurosciences</source><volume>30</volume><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2007.03.006</pub-id><pub-id pub-id-type="pmid">17408759</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero</surname><given-names>A</given-names></name><name><surname>Tseng</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GABAergic function as a limiting factor for prefrontal maturation during adolescence</article-title><source>Trends in Neurosciences</source><volume>39</volume><fpage>441</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2016.04.010</pub-id><pub-id pub-id-type="pmid">27233681</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>VY</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Mastwal</surname><given-names>SS</given-names></name><name><surname>Lovinger</surname><given-names>DM</given-names></name><name><surname>Costa</surname><given-names>RM</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>In vivo two-photon imaging of experience-dependent molecular changes in cortical neurons</article-title><source>Journal of Visualized Experiments</source><volume>1</volume><elocation-id>50148</elocation-id><pub-id pub-id-type="doi">10.3791/50148</pub-id><pub-id pub-id-type="pmid">23329071</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>VY</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Mastwal</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Coon</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Costa</surname><given-names>RM</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Motor learning consolidates arc-expressing neuronal ensembles in secondary motor cortex</article-title><source>Neuron</source><volume>86</volume><fpage>1385</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.022</pub-id><pub-id pub-id-type="pmid">26051420</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castner</surname><given-names>SA</given-names></name><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation</article-title><source>Science</source><volume>287</volume><fpage>2020</fpage><lpage>2022</lpage><pub-id pub-id-type="doi">10.1126/science.287.5460.2020</pub-id><pub-id pub-id-type="pmid">10720329</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>RA</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name><name><surname>Potenza</surname><given-names>MN</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability</article-title><source>The American Journal of Psychiatry</source><volume>160</volume><fpage>1041</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.160.6.1041</pub-id><pub-id pub-id-type="pmid">12777258</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T-W</given-names></name><name><surname>Wardill</surname><given-names>TJ</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Pulver</surname><given-names>SR</given-names></name><name><surname>Renninger</surname><given-names>SL</given-names></name><name><surname>Baohan</surname><given-names>A</given-names></name><name><surname>Schreiter</surname><given-names>ER</given-names></name><name><surname>Kerr</surname><given-names>RA</given-names></name><name><surname>Orger</surname><given-names>MB</given-names></name><name><surname>Jayaraman</surname><given-names>V</given-names></name><name><surname>Looger</surname><given-names>LL</given-names></name><name><surname>Svoboda</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ultrasensitive fluorescent proteins for imaging neuronal activity</article-title><source>Nature</source><volume>499</volume><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1038/nature12354</pub-id><pub-id pub-id-type="pmid">23868258</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahl</surname><given-names>RE</given-names></name><name><surname>Allen</surname><given-names>NB</given-names></name><name><surname>Wilbrecht</surname><given-names>L</given-names></name><name><surname>Suleiman</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Importance of investing in adolescence from a developmental science perspective</article-title><source>Nature</source><volume>554</volume><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1038/nature25770</pub-id><pub-id pub-id-type="pmid">29469094</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalley</surname><given-names>JW</given-names></name><name><surname>Cardinal</surname><given-names>RN</given-names></name><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>28</volume><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2004.09.006</pub-id><pub-id pub-id-type="pmid">15555683</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>M</given-names></name><name><surname>Galderisi</surname><given-names>S</given-names></name><name><surname>Weiser</surname><given-names>M</given-names></name><name><surname>Werbeloff</surname><given-names>N</given-names></name><name><surname>Fleischhacker</surname><given-names>WW</given-names></name><name><surname>Keefe</surname><given-names>RS</given-names></name><name><surname>Boter</surname><given-names>H</given-names></name><name><surname>Keet</surname><given-names>IPM</given-names></name><name><surname>Prelipceanu</surname><given-names>D</given-names></name><name><surname>Rybakowski</surname><given-names>JK</given-names></name><name><surname>Libiger</surname><given-names>J</given-names></name><name><surname>Hummer</surname><given-names>M</given-names></name><name><surname>Dollfus</surname><given-names>S</given-names></name><name><surname>López-Ibor</surname><given-names>JJ</given-names></name><name><surname>Hranov</surname><given-names>LG</given-names></name><name><surname>Gaebel</surname><given-names>W</given-names></name><name><surname>Peuskens</surname><given-names>J</given-names></name><name><surname>Lindefors</surname><given-names>N</given-names></name><name><surname>Riecher-Rössler</surname><given-names>A</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)</article-title><source>The American Journal of Psychiatry</source><volume>166</volume><fpage>675</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2008.08060806</pub-id><pub-id pub-id-type="pmid">19369319</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dazzi</surname><given-names>L</given-names></name><name><surname>Seu</surname><given-names>E</given-names></name><name><surname>Cherchi</surname><given-names>G</given-names></name><name><surname>Barbieri</surname><given-names>PP</given-names></name><name><surname>Matzeu</surname><given-names>A</given-names></name><name><surname>Biggio</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Estrous cycle-dependent changes in basal and ethanol-induced activity of cortical dopaminergic neurons in the rat</article-title><source>Neuropsychopharmacology</source><volume>32</volume><fpage>892</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301150</pub-id><pub-id pub-id-type="pmid">16841076</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delatour</surname><given-names>B</given-names></name><name><surname>Gisquet-Verrier</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat</article-title><source>Behavioral Neuroscience</source><volume>110</volume><fpage>1282</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1037//0735-7044.110.6.1282</pub-id><pub-id pub-id-type="pmid">8986332</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divac</surname><given-names>I</given-names></name><name><surname>Wikmark</surname><given-names>RGE</given-names></name><name><surname>Gade</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Spontaneous alternation in rats with lesions in the frontal lobes: An extension of the frontal lobe syndrome</article-title><source>Physiological Psychology</source><volume>3</volume><fpage>39</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.3758/BF03326820</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Boustani</surname><given-names>S</given-names></name><name><surname>Ip</surname><given-names>JPK</given-names></name><name><surname>Breton-Provencher</surname><given-names>V</given-names></name><name><surname>Knott</surname><given-names>GW</given-names></name><name><surname>Okuno</surname><given-names>H</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Sur</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Locally coordinated synaptic plasticity of visual cortex neurons in vivo</article-title><source>Science</source><volume>360</volume><fpage>1349</fpage><lpage>1354</lpage><pub-id pub-id-type="doi">10.1126/science.aao0862</pub-id><pub-id pub-id-type="pmid">29930137</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellwood</surname><given-names>IT</given-names></name><name><surname>Patel</surname><given-names>T</given-names></name><name><surname>Wadia</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Liptak</surname><given-names>AT</given-names></name><name><surname>Bender</surname><given-names>KJ</given-names></name><name><surname>Sohal</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tonic or phasic stimulation of dopaminergic projections to prefrontal cortex causes mice to maintain or deviate from previously learned behavioral strategies</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>8315</fpage><lpage>8329</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1221-17.2017</pub-id><pub-id pub-id-type="pmid">28739583</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions</article-title><source>Frontiers in Neuroscience</source><volume>7</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2013.00062</pub-id><pub-id pub-id-type="pmid">23626521</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>AD</given-names></name><name><surname>Coto</surname><given-names>CA</given-names></name><name><surname>Siegel</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Animal models of psychosis: Current state and future directions</article-title><source>Current Behavioral Neuroscience Reports</source><volume>1</volume><fpage>100</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1007/s40473-014-0013-2</pub-id><pub-id pub-id-type="pmid">25215267</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Pocklington</surname><given-names>AJ</given-names></name><name><surname>Kavanagh</surname><given-names>DH</given-names></name><name><surname>Williams</surname><given-names>HJ</given-names></name><name><surname>Dwyer</surname><given-names>S</given-names></name><name><surname>Gormley</surname><given-names>P</given-names></name><name><surname>Georgieva</surname><given-names>L</given-names></name><name><surname>Rees</surname><given-names>E</given-names></name><name><surname>Palta</surname><given-names>P</given-names></name><name><surname>Ruderfer</surname><given-names>DM</given-names></name><name><surname>Carrera</surname><given-names>N</given-names></name><name><surname>Humphreys</surname><given-names>I</given-names></name><name><surname>Johnson</surname><given-names>JS</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Barker</surname><given-names>DD</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Milanova</surname><given-names>V</given-names></name><name><surname>Grant</surname><given-names>SG</given-names></name><name><surname>Hannon</surname><given-names>E</given-names></name><name><surname>Rose</surname><given-names>SA</given-names></name><name><surname>Chambert</surname><given-names>K</given-names></name><name><surname>Mahajan</surname><given-names>M</given-names></name><name><surname>Scolnick</surname><given-names>EM</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Palotie</surname><given-names>A</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Holmans</surname><given-names>P</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title><source>Nature</source><volume>506</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nature12929</pub-id><pub-id pub-id-type="pmid">24463507</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fuster</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2008">2008</year><source>The Prefrontal Cortex</source><publisher-loc>Amsterdam ; Boston</publisher-loc><publisher-name>Academic Press/Elsevier</publisher-name></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Grendel</surname><given-names>J</given-names></name><name><surname>Muhia</surname><given-names>M</given-names></name><name><surname>Castro-Gomez</surname><given-names>S</given-names></name><name><surname>Süsens</surname><given-names>U</given-names></name><name><surname>Isbrandt</surname><given-names>D</given-names></name><name><surname>Kneussel</surname><given-names>M</given-names></name><name><surname>Kuhl</surname><given-names>D</given-names></name><name><surname>Ohana</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Disturbed prefrontal cortex activity in the absence of schizophrenia-like behavioral dysfunction in <italic>Arc/Arg3.1</italic> Deficient mice</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>8149</fpage><lpage>8163</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0623-19.2019</pub-id><pub-id pub-id-type="pmid">31488612</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>KK</given-names></name><name><surname>Burns</surname><given-names>LD</given-names></name><name><surname>Cocker</surname><given-names>ED</given-names></name><name><surname>Nimmerjahn</surname><given-names>A</given-names></name><name><surname>Ziv</surname><given-names>Y</given-names></name><name><surname>Gamal</surname><given-names>AE</given-names></name><name><surname>Schnitzer</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Miniaturized integration of a fluorescence microscope</article-title><source>Nature Methods</source><volume>8</volume><fpage>871</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1694</pub-id><pub-id pub-id-type="pmid">21909102</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gireesh</surname><given-names>ED</given-names></name><name><surname>Plenz</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuronal avalanches organize as nested theta- and beta/gamma-oscillations during development of cortical layer 2/3</article-title><source>PNAS</source><volume>105</volume><fpage>7576</fpage><lpage>7581</lpage><pub-id pub-id-type="doi">10.1073/pnas.0800537105</pub-id><pub-id pub-id-type="pmid">18499802</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girgis</surname><given-names>RR</given-names></name><name><surname>Van Snellenberg</surname><given-names>JX</given-names></name><name><surname>Glass</surname><given-names>A</given-names></name><name><surname>Kegeles</surname><given-names>LS</given-names></name><name><surname>Thompson</surname><given-names>JL</given-names></name><name><surname>Wall</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>RY</given-names></name><name><surname>Carter</surname><given-names>CS</given-names></name><name><surname>Slifstein</surname><given-names>M</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A proof-of-concept, randomized controlled trial of DAR-0100A, A dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia</article-title><source>Journal of Psychopharmacology</source><volume>30</volume><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1177/0269881116636120</pub-id><pub-id pub-id-type="pmid">26966119</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goff</surname><given-names>DC</given-names></name><name><surname>Hill</surname><given-names>M</given-names></name><name><surname>Barch</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The treatment of cognitive impairment in schizophrenia</article-title><source>Pharmacology, Biochemistry, and Behavior</source><volume>99</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.pbb.2010.11.009</pub-id><pub-id pub-id-type="pmid">21115035</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name><name><surname>Leranth</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>SM</given-names></name><name><surname>Mons</surname><given-names>N</given-names></name><name><surname>Geffard</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex</article-title><source>PNAS</source><volume>86</volume><fpage>9015</fpage><lpage>9019</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.22.9015</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>S</given-names></name><name><surname>Doughty</surname><given-names>M</given-names></name><name><surname>Harbaugh</surname><given-names>CR</given-names></name><name><surname>Cummins</surname><given-names>A</given-names></name><name><surname>Hatten</surname><given-names>ME</given-names></name><name><surname>Heintz</surname><given-names>N</given-names></name><name><surname>Gerfen</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs</article-title><source>The Journal of Neuroscience</source><volume>27</volume><fpage>9817</fpage><lpage>9823</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2707-07.2007</pub-id><pub-id pub-id-type="pmid">17855595</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Stimulating the development of drug treatments to improve cognition in schizophrenia</article-title><source>Annual Review of Clinical Psychology</source><volume>3</volume><fpage>159</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1146/annurev.clinpsy.3.022806.091529</pub-id><pub-id pub-id-type="pmid">17716052</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunaydin</surname><given-names>LA</given-names></name><name><surname>Grosenick</surname><given-names>L</given-names></name><name><surname>Finkelstein</surname><given-names>JC</given-names></name><name><surname>Kauvar</surname><given-names>IV</given-names></name><name><surname>Fenno</surname><given-names>LE</given-names></name><name><surname>Adhikari</surname><given-names>A</given-names></name><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Mirzabekov</surname><given-names>JJ</given-names></name><name><surname>Airan</surname><given-names>RD</given-names></name><name><surname>Zalocusky</surname><given-names>KA</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name><name><surname>Anikeeva</surname><given-names>P</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Natural neural projection dynamics underlying social behavior</article-title><source>Cell</source><volume>157</volume><fpage>1535</fpage><lpage>1551</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.05.017</pub-id><pub-id pub-id-type="pmid">24949967</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoops</surname><given-names>D</given-names></name><name><surname>Flores</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Making dopamine connections in adolescence</article-title><source>Trends in Neurosciences</source><volume>40</volume><fpage>709</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2017.09.004</pub-id><pub-id pub-id-type="pmid">29032842</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howes</surname><given-names>OD</given-names></name><name><surname>Kapur</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The dopamine hypothesis of schizophrenia: version III--the final common pathway</article-title><source>Schizophrenia Bulletin</source><volume>35</volume><fpage>549</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbp006</pub-id><pub-id pub-id-type="pmid">19325164</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyvärinen</surname><given-names>A</given-names></name><name><surname>Oja</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Independent component analysis: algorithms and applications</article-title><source>Neural Networks</source><volume>13</volume><fpage>411</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/s0893-6080(00)00026-5</pub-id><pub-id pub-id-type="pmid">10946390</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Rethinking schizophrenia</article-title><source>Nature</source><volume>468</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1038/nature09552</pub-id><pub-id pub-id-type="pmid">21068826</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishizuka</surname><given-names>K</given-names></name><name><surname>Paek</surname><given-names>M</given-names></name><name><surname>Kamiya</surname><given-names>A</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions</article-title><source>Biological Psychiatry</source><volume>59</volume><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.065</pub-id><pub-id pub-id-type="pmid">16797264</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>HT</given-names></name><name><surname>Zhang</surname><given-names>SJ</given-names></name><name><surname>Witter</surname><given-names>MP</given-names></name><name><surname>Moser</surname><given-names>EI</given-names></name><name><surname>Moser</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A prefrontal-thalamo-hippocampal circuit for goal-directed spatial navigation</article-title><source>Nature</source><volume>522</volume><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1038/nature14396</pub-id><pub-id pub-id-type="pmid">26017312</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jobson</surname><given-names>CLM</given-names></name><name><surname>Renard</surname><given-names>J</given-names></name><name><surname>Szkudlarek</surname><given-names>H</given-names></name><name><surname>Rosen</surname><given-names>LG</given-names></name><name><surname>Pereira</surname><given-names>B</given-names></name><name><surname>Wright</surname><given-names>DJ</given-names></name><name><surname>Rushlow</surname><given-names>W</given-names></name><name><surname>Laviolette</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Adolescent nicotine exposure induces dysregulation of mesocorticolimbic activity states and depressive and anxiety-like prefrontal cortical molecular phenotypes persisting into adulthood</article-title><source>Cerebral Cortex</source><volume>29</volume><fpage>3140</fpage><lpage>3153</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhy179</pub-id><pub-id pub-id-type="pmid">30124787</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalsbeek</surname><given-names>A</given-names></name><name><surname>Voorn</surname><given-names>P</given-names></name><name><surname>Buijs</surname><given-names>RM</given-names></name><name><surname>Pool</surname><given-names>CW</given-names></name><name><surname>Uylings</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Development of the dopaminergic innervation in the prefrontal cortex of the rat</article-title><source>The Journal of Comparative Neurology</source><volume>269</volume><fpage>58</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/cne.902690105</pub-id><pub-id pub-id-type="pmid">3361004</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keefe</surname><given-names>RSE</given-names></name><name><surname>Seidman</surname><given-names>LJ</given-names></name><name><surname>Christensen</surname><given-names>BK</given-names></name><name><surname>Hamer</surname><given-names>RM</given-names></name><name><surname>Sharma</surname><given-names>T</given-names></name><name><surname>Sitskoorn</surname><given-names>MM</given-names></name><name><surname>Lewine</surname><given-names>RRJ</given-names></name><name><surname>Yurgelun-Todd</surname><given-names>DA</given-names></name><name><surname>Gur</surname><given-names>RC</given-names></name><name><surname>Tohen</surname><given-names>M</given-names></name><name><surname>Tollefson</surname><given-names>GD</given-names></name><name><surname>Sanger</surname><given-names>TM</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol</article-title><source>The American Journal of Psychiatry</source><volume>161</volume><fpage>985</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.161.6.985</pub-id><pub-id pub-id-type="pmid">15169686</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>N-S</given-names></name><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>Y-T</given-names></name><name><surname>Yoon</surname><given-names>K-J</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Sakamuru</surname><given-names>S</given-names></name><name><surname>Christian</surname><given-names>KM</given-names></name><name><surname>Hsu</surname><given-names>K-S</given-names></name><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Margolis</surname><given-names>RL</given-names></name><name><surname>Lu</surname><given-names>X-Y</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>G-L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Author Correction: Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2570</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-23263-0</pub-id><pub-id pub-id-type="pmid">33931639</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirov</surname><given-names>G</given-names></name><name><surname>Pocklington</surname><given-names>AJ</given-names></name><name><surname>Holmans</surname><given-names>P</given-names></name><name><surname>Ivanov</surname><given-names>D</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Ruderfer</surname><given-names>D</given-names></name><name><surname>Moran</surname><given-names>J</given-names></name><name><surname>Chambert</surname><given-names>K</given-names></name><name><surname>Toncheva</surname><given-names>D</given-names></name><name><surname>Georgieva</surname><given-names>L</given-names></name><name><surname>Grozeva</surname><given-names>D</given-names></name><name><surname>Fjodorova</surname><given-names>M</given-names></name><name><surname>Wollerton</surname><given-names>R</given-names></name><name><surname>Rees</surname><given-names>E</given-names></name><name><surname>Nikolov</surname><given-names>I</given-names></name><name><surname>van de Lagemaat</surname><given-names>LN</given-names></name><name><surname>Bayés</surname><given-names>A</given-names></name><name><surname>Fernandez</surname><given-names>E</given-names></name><name><surname>Olason</surname><given-names>PI</given-names></name><name><surname>Böttcher</surname><given-names>Y</given-names></name><name><surname>Komiyama</surname><given-names>NH</given-names></name><name><surname>Collins</surname><given-names>MO</given-names></name><name><surname>Choudhary</surname><given-names>J</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Stefansson</surname><given-names>H</given-names></name><name><surname>Grant</surname><given-names>SGN</given-names></name><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>O’Donovan</surname><given-names>MC</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia</article-title><source>Molecular Psychiatry</source><volume>17</volume><fpage>142</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/mp.2011.154</pub-id><pub-id pub-id-type="pmid">22083728</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalonde</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The neurobiological basis of spontaneous alternation</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>26</volume><fpage>91</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/s0149-7634(01)00041-0</pub-id><pub-id pub-id-type="pmid">11835987</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambe</surname><given-names>EK</given-names></name><name><surname>Krimer</surname><given-names>LS</given-names></name><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>8780</fpage><lpage>8787</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-23-08780.2000</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Hetzel</surname><given-names>A</given-names></name><name><surname>Häckel</surname><given-names>O</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><name><surname>Liss</surname><given-names>B</given-names></name><name><surname>Roeper</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system</article-title><source>Neuron</source><volume>57</volume><fpage>760</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.01.022</pub-id><pub-id pub-id-type="pmid">18341995</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>BK</given-names></name><name><surname>Ran</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>KW</given-names></name><name><surname>Betley</surname><given-names>MJ</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Input-specific control of reward and aversion in the ventral tegmental area</article-title><source>Nature</source><volume>491</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/nature11527</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammel</surname><given-names>S</given-names></name><name><surname>Steinberg</surname><given-names>EE</given-names></name><name><surname>Földy</surname><given-names>C</given-names></name><name><surname>Wall</surname><given-names>NR</given-names></name><name><surname>Beier</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons</article-title><source>Neuron</source><volume>85</volume><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.036</pub-id><pub-id pub-id-type="pmid">25611513</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>B</given-names></name><name><surname>Luna</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Adolescence as a neurobiological critical period for the development of higher-order cognition</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>94</volume><fpage>179</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.09.005</pub-id><pub-id pub-id-type="pmid">30201220</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavin</surname><given-names>A</given-names></name><name><surname>Nogueira</surname><given-names>L</given-names></name><name><surname>Lapish</surname><given-names>CC</given-names></name><name><surname>Wightman</surname><given-names>RM</given-names></name><name><surname>Phillips</surname><given-names>PEM</given-names></name><name><surname>Seamans</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling</article-title><source>The Journal of Neuroscience</source><volume>25</volume><fpage>5013</fpage><lpage>5023</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0557-05.2005</pub-id><pub-id pub-id-type="pmid">15901782</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Moal</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Mesocorticolimbic dopaminergic network: functional and regulatory roles</article-title><source>Physiological Reviews</source><volume>71</volume><fpage>155</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1152/physrev.1991.71.1.155</pub-id><pub-id pub-id-type="pmid">1986388</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerner</surname><given-names>TN</given-names></name><name><surname>Shilyansky</surname><given-names>C</given-names></name><name><surname>Davidson</surname><given-names>TJ</given-names></name><name><surname>Evans</surname><given-names>KE</given-names></name><name><surname>Beier</surname><given-names>KT</given-names></name><name><surname>Zalocusky</surname><given-names>KA</given-names></name><name><surname>Crow</surname><given-names>AK</given-names></name><name><surname>Malenka</surname><given-names>RC</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Tomer</surname><given-names>R</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits</article-title><source>Cell</source><volume>162</volume><fpage>635</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.07.014</pub-id><pub-id pub-id-type="pmid">26232229</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>BL</given-names></name><name><surname>O’Donnell</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential “up” states in pyramidal neurons via D(1) dopamine receptors</article-title><source>Cerebral Cortex</source><volume>10</volume><fpage>1168</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.1093/cercor/10.12.1168</pub-id><pub-id pub-id-type="pmid">11073866</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Micheva</surname><given-names>KD</given-names></name><name><surname>Ivanov</surname><given-names>VM</given-names></name><name><surname>Spletter</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>SJ</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Visualizing the distribution of synapses from individual neurons in the mouse brain</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e11503</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0011503</pub-id><pub-id pub-id-type="pmid">20634890</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>HL</given-names></name><name><surname>Morales</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties</article-title><source>Brain Structure &amp; Function</source><volume>218</volume><fpage>1159</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.1007/s00429-012-0452-z</pub-id><pub-id pub-id-type="pmid">22926514</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>VY</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Mastwal</surname><given-names>SS</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Otte</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Skin suturing and cortical surface viral infusion improves imaging of neuronal ensemble activity with head-mounted miniature microscopes</article-title><source>Journal of Neuroscience Methods</source><volume>291</volume><fpage>238</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2017.08.016</pub-id><pub-id pub-id-type="pmid">28830724</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Latremoliere</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Alexandre</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>J-Y</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>He</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Touch and tactile neuropathic pain sensitivity are set by corticospinal projections</article-title><source>Nature</source><volume>561</volume><fpage>547</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0515-2</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Goel</surname><given-names>P</given-names></name><name><surname>Kaeser</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Spatial and temporal scales of dopamine transmission</article-title><source>Nature Reviews. Neuroscience</source><volume>22</volume><fpage>345</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1038/s41583-021-00455-7</pub-id><pub-id pub-id-type="pmid">33837376</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohani</surname><given-names>S</given-names></name><name><surname>Martig</surname><given-names>AK</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Witten</surname><given-names>IB</given-names></name><name><surname>Moghaddam</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dopamine modulation of prefrontal cortex activity is manifold and operates at multiple temporal and spatial scales</article-title><source>Cell Reports</source><volume>27</volume><fpage>99</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.012</pub-id><pub-id pub-id-type="pmid">30943418</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lüscher</surname><given-names>C</given-names></name><name><surname>Pascoli</surname><given-names>V</given-names></name><name><surname>Creed</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Optogenetic dissection of neural circuitry: from synaptic causalities to blue prints for novel treatments of behavioral diseases</article-title><source>Current Opinion in Neurobiology</source><volume>35</volume><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2015.07.005</pub-id><pub-id pub-id-type="pmid">26264408</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Managò</surname><given-names>F</given-names></name><name><surname>Mereu</surname><given-names>M</given-names></name><name><surname>Mastwal</surname><given-names>S</given-names></name><name><surname>Mastrogiacomo</surname><given-names>R</given-names></name><name><surname>Scheggia</surname><given-names>D</given-names></name><name><surname>Emanuele</surname><given-names>M</given-names></name><name><surname>De Luca</surname><given-names>MA</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name><name><surname>Papaleo</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic disruption of Arc/Arg3.1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia</article-title><source>Cell Reports</source><volume>16</volume><fpage>2116</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.07.044</pub-id><pub-id pub-id-type="pmid">27524619</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manion</surname><given-names>MTC</given-names></name><name><surname>Glasper</surname><given-names>ER</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A sex difference in mouse dopaminergic projections from the midbrain to basolateral amygdala</article-title><source>Biology of Sex Differences</source><volume>13</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1186/s13293-022-00486-4</pub-id><pub-id pub-id-type="pmid">36585727</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marder</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia</article-title><source>Dialogues in Clinical Neuroscience</source><volume>8</volume><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2006.8.1/smarder</pub-id><pub-id pub-id-type="pmid">16640121</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastwal</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Jimenez</surname><given-names>DV</given-names></name><name><surname>Martinowich</surname><given-names>K</given-names></name><name><surname>Gerfen</surname><given-names>CR</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>9484</fpage><lpage>9496</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1114-14.2014</pub-id><pub-id pub-id-type="pmid">25031392</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastwal</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic feedback regulation of frontal cortical neuronal ensembles through activity-dependent arc expression and dopaminergic input</article-title><source>Frontiers in Neural Circuits</source><volume>10</volume><elocation-id>100</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2016.00100</pub-id><pub-id pub-id-type="pmid">27999532</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>EK</given-names></name><name><surname>Cohen</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>An integrative theory of prefrontal cortex function</article-title><source>Annual Review of Neuroscience</source><volume>24</volume><fpage>167</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.24.1.167</pub-id><pub-id pub-id-type="pmid">11283309</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>S</given-names></name><name><surname>Duncan</surname><given-names>GE</given-names></name><name><surname>Marx</surname><given-names>CE</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs</article-title><source>Molecular Psychiatry</source><volume>10</volume><fpage>79</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4001556</pub-id><pub-id pub-id-type="pmid">15289815</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>M</given-names></name><name><surname>Margolis</surname><given-names>EB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ventral tegmental area: cellular heterogeneity, connectivity and behaviour</article-title><source>Nature Reviews. Neuroscience</source><volume>18</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1038/nrn.2016.165</pub-id><pub-id pub-id-type="pmid">28053327</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukamel</surname><given-names>EA</given-names></name><name><surname>Nimmerjahn</surname><given-names>A</given-names></name><name><surname>Schnitzer</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Automated analysis of cellular signals from large-scale calcium imaging data</article-title><source>Neuron</source><volume>63</volume><fpage>747</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.009</pub-id><pub-id pub-id-type="pmid">19778505</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Carvalho</surname><given-names>F</given-names></name><name><surname>Eliez</surname><given-names>S</given-names></name><name><surname>Caroni</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Long-lasting rescue of network and cognitive dysfunction in a genetic schizophrenia model</article-title><source>Cell</source><volume>178</volume><fpage>1387</fpage><lpage>1402</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.07.023</pub-id><pub-id pub-id-type="pmid">31474363</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murty</surname><given-names>VP</given-names></name><name><surname>Calabro</surname><given-names>F</given-names></name><name><surname>Luna</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of experience in adolescent cognitive development: Integration of executive, memory, and mesolimbic systems</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>70</volume><fpage>46</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.07.034</pub-id><pub-id pub-id-type="pmid">27477444</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naneix</surname><given-names>F</given-names></name><name><surname>Marchand</surname><given-names>AR</given-names></name><name><surname>Di Scala</surname><given-names>G</given-names></name><name><surname>Pape</surname><given-names>JR</given-names></name><name><surname>Coutureau</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>16223</fpage><lpage>16232</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3080-12.2012</pub-id><pub-id pub-id-type="pmid">23152606</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naneix</surname><given-names>F</given-names></name><name><surname>Marchand</surname><given-names>AR</given-names></name><name><surname>Pichon</surname><given-names>A</given-names></name><name><surname>Pape</surname><given-names>JR</given-names></name><name><surname>Coutureau</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adolescent stimulation of D2 receptors alters the maturation of dopamine-dependent goal-directed behavior</article-title><source>Neuropsychopharmacology</source><volume>38</volume><fpage>1566</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1038/npp.2013.55</pub-id><pub-id pub-id-type="pmid">23443719</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>M</given-names></name><name><surname>Kamiya</surname><given-names>A</given-names></name><name><surname>Murai</surname><given-names>R</given-names></name><name><surname>Kubo</surname><given-names>K</given-names></name><name><surname>Gruber</surname><given-names>AJ</given-names></name><name><surname>Tomita</surname><given-names>K</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Tomisato</surname><given-names>S</given-names></name><name><surname>Jaaro-Peled</surname><given-names>H</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Hiyama</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Kohda</surname><given-names>K</given-names></name><name><surname>Noda</surname><given-names>Y</given-names></name><name><surname>O’Donnell</surname><given-names>P</given-names></name><name><surname>Nakajima</surname><given-names>K</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name><name><surname>Nabeshima</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits</article-title><source>Neuron</source><volume>65</volume><fpage>480</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.019</pub-id><pub-id pub-id-type="pmid">20188653</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niwa</surname><given-names>M</given-names></name><name><surname>Jaaro-Peled</surname><given-names>H</given-names></name><name><surname>Tankou</surname><given-names>S</given-names></name><name><surname>Seshadri</surname><given-names>S</given-names></name><name><surname>Hikida</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>Y</given-names></name><name><surname>Cascella</surname><given-names>NG</given-names></name><name><surname>Kano</surname><given-names>S</given-names></name><name><surname>Ozaki</surname><given-names>N</given-names></name><name><surname>Nabeshima</surname><given-names>T</given-names></name><name><surname>Sawa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids</article-title><source>Science</source><volume>339</volume><fpage>335</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1126/science.1226931</pub-id><pub-id pub-id-type="pmid">23329051</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Adolescent maturation of cortical dopamine</article-title><source>Neurotoxicity Research</source><volume>18</volume><fpage>306</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/s12640-010-9157-3</pub-id><pub-id pub-id-type="pmid">20151241</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Donnell</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Adolescent onset of cortical disinhibition in schizophrenia: insights from animal models</article-title><source>Schizophrenia Bulletin</source><volume>37</volume><fpage>484</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbr028</pub-id><pub-id pub-id-type="pmid">21505115</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Harris</surname><given-names>JA</given-names></name><name><surname>Ng</surname><given-names>L</given-names></name><name><surname>Winslow</surname><given-names>B</given-names></name><name><surname>Cain</surname><given-names>N</given-names></name><name><surname>Mihalas</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Lau</surname><given-names>C</given-names></name><name><surname>Kuan</surname><given-names>L</given-names></name><name><surname>Henry</surname><given-names>AM</given-names></name><name><surname>Mortrud</surname><given-names>MT</given-names></name><name><surname>Ouellette</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>TN</given-names></name><name><surname>Sorensen</surname><given-names>SA</given-names></name><name><surname>Slaughterbeck</surname><given-names>CR</given-names></name><name><surname>Wakeman</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name><name><surname>Nicholas</surname><given-names>E</given-names></name><name><surname>Hirokawa</surname><given-names>KE</given-names></name><name><surname>Bohn</surname><given-names>P</given-names></name><name><surname>Joines</surname><given-names>KM</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Phillips</surname><given-names>JW</given-names></name><name><surname>Hohmann</surname><given-names>JG</given-names></name><name><surname>Wohnoutka</surname><given-names>P</given-names></name><name><surname>Gerfen</surname><given-names>CR</given-names></name><name><surname>Koch</surname><given-names>C</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><name><surname>Dang</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A mesoscale connectome of the mouse brain</article-title><source>Nature</source><volume>508</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/nature13186</pub-id><pub-id pub-id-type="pmid">24695228</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patriarchi</surname><given-names>T</given-names></name><name><surname>Cho</surname><given-names>JR</given-names></name><name><surname>Merten</surname><given-names>K</given-names></name><name><surname>Howe</surname><given-names>MW</given-names></name><name><surname>Marley</surname><given-names>A</given-names></name><name><surname>Xiong</surname><given-names>W-H</given-names></name><name><surname>Folk</surname><given-names>RW</given-names></name><name><surname>Broussard</surname><given-names>GJ</given-names></name><name><surname>Liang</surname><given-names>R</given-names></name><name><surname>Jang</surname><given-names>MJ</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Dombeck</surname><given-names>D</given-names></name><name><surname>von Zastrow</surname><given-names>M</given-names></name><name><surname>Nimmerjahn</surname><given-names>A</given-names></name><name><surname>Gradinaru</surname><given-names>V</given-names></name><name><surname>Williams</surname><given-names>JT</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors</article-title><source>Science</source><volume>360</volume><elocation-id>1420</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat4422</pub-id><pub-id pub-id-type="pmid">29853555</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paus</surname><given-names>T</given-names></name><name><surname>Keshavan</surname><given-names>M</given-names></name><name><surname>Giedd</surname><given-names>JN</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Why do many psychiatric disorders emerge during adolescence?</article-title><source>Nature Reviews. Neuroscience</source><volume>9</volume><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1038/nrn2513</pub-id><pub-id pub-id-type="pmid">19002191</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penrod</surname><given-names>RD</given-names></name><name><surname>Kumar</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>LN</given-names></name><name><surname>McCalley</surname><given-names>D</given-names></name><name><surname>Nentwig</surname><given-names>TB</given-names></name><name><surname>Hughes</surname><given-names>BW</given-names></name><name><surname>Barry</surname><given-names>GM</given-names></name><name><surname>Glover</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Activity-regulated cytoskeleton-associated protein (Arc/Arg3.1) regulates anxiety- and novelty-related behaviors</article-title><source>Genes, Brain, and Behavior</source><volume>18</volume><elocation-id>e12561</elocation-id><pub-id pub-id-type="doi">10.1111/gbb.12561</pub-id><pub-id pub-id-type="pmid">30761730</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pioli</surname><given-names>EY</given-names></name><name><surname>Meissner</surname><given-names>W</given-names></name><name><surname>Sohr</surname><given-names>R</given-names></name><name><surname>Gross</surname><given-names>CE</given-names></name><name><surname>Bezard</surname><given-names>E</given-names></name><name><surname>Bioulac</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats</article-title><source>Neuroscience</source><volume>153</volume><fpage>1213</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.01.084</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>LL</given-names></name><name><surname>Rizzo</surname><given-names>E</given-names></name><name><surname>Hornung</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Dopamine affects parvalbumin expression during cortical development <italic>In Vitro</italic></article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>8990</fpage><lpage>9003</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-20-08990.1999</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>SM</given-names></name><name><surname>Moran</surname><given-names>JL</given-names></name><name><surname>Fromer</surname><given-names>M</given-names></name><name><surname>Ruderfer</surname><given-names>D</given-names></name><name><surname>Solovieff</surname><given-names>N</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>O’Dushlaine</surname><given-names>C</given-names></name><name><surname>Chambert</surname><given-names>K</given-names></name><name><surname>Bergen</surname><given-names>SE</given-names></name><name><surname>Kähler</surname><given-names>A</given-names></name><name><surname>Duncan</surname><given-names>L</given-names></name><name><surname>Stahl</surname><given-names>E</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Fernández</surname><given-names>E</given-names></name><name><surname>Collins</surname><given-names>MO</given-names></name><name><surname>Komiyama</surname><given-names>NH</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Magnusson</surname><given-names>PKE</given-names></name><name><surname>Banks</surname><given-names>E</given-names></name><name><surname>Shakir</surname><given-names>K</given-names></name><name><surname>Garimella</surname><given-names>K</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>DePristo</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>SGN</given-names></name><name><surname>Haggarty</surname><given-names>SJ</given-names></name><name><surname>Gabriel</surname><given-names>S</given-names></name><name><surname>Scolnick</surname><given-names>EM</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hultman</surname><given-names>CM</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title><source>Nature</source><volume>506</volume><fpage>185</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/nature12975</pub-id><pub-id pub-id-type="pmid">24463508</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>LM</given-names></name><name><surname>Yetnikoff</surname><given-names>L</given-names></name><name><surname>Pokinko</surname><given-names>M</given-names></name><name><surname>Wodzinski</surname><given-names>M</given-names></name><name><surname>Epelbaum</surname><given-names>JG</given-names></name><name><surname>Lambert</surname><given-names>LC</given-names></name><name><surname>Cossette</surname><given-names>MP</given-names></name><name><surname>Arvanitogiannis</surname><given-names>A</given-names></name><name><surname>Flores</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Early adolescence is a critical period for the maturation of inhibitory behavior</article-title><source>Cerebral Cortex</source><volume>29</volume><fpage>3676</fpage><lpage>3686</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhy247</pub-id><pub-id pub-id-type="pmid">30295713</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richman</surname><given-names>CL</given-names></name><name><surname>Dember</surname><given-names>WN</given-names></name><name><surname>Kim</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Spontaneous alternation behavior in animals: A review</article-title><source>Current Psychological Research &amp; Reviews</source><volume>5</volume><fpage>358</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1007/BF02686603</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbins</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Chemical neuromodulation of frontal-executive functions in humans and other animals</article-title><source>Experimental Brain Research</source><volume>133</volume><fpage>130</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1007/s002210000407</pub-id><pub-id pub-id-type="pmid">10933217</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolls</surname><given-names>ET</given-names></name><name><surname>Loh</surname><given-names>M</given-names></name><name><surname>Deco</surname><given-names>G</given-names></name><name><surname>Winterer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Computational models of schizophrenia and dopamine modulation in the prefrontal cortex</article-title><source>Nature Reviews. Neuroscience</source><volume>9</volume><fpage>696</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1038/nrn2462</pub-id><pub-id pub-id-type="pmid">18714326</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>DR</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis</article-title><source>The Journal of Comparative Neurology</source><volume>358</volume><fpage>383</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1002/cne.903580306</pub-id><pub-id pub-id-type="pmid">7560293</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>DREADDs for Neuroscientists</article-title><source>Neuron</source><volume>89</volume><fpage>683</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.01.040</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rushworth</surname><given-names>MFS</given-names></name><name><surname>Kolling</surname><given-names>N</given-names></name><name><surname>Sallet</surname><given-names>J</given-names></name><name><surname>Mars</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Valuation and decision-making in frontal cortex: one or many serial or parallel systems?</article-title><source>Current Opinion in Neurobiology</source><volume>22</volume><fpage>946</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2012.04.011</pub-id><pub-id pub-id-type="pmid">22572389</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Chant</surname><given-names>D</given-names></name><name><surname>Welham</surname><given-names>J</given-names></name><name><surname>McGrath</surname><given-names>J</given-names></name><name><surname>Hyman</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A systematic review of the prevalence of schizophrenia</article-title><source>PLOS Medicine</source><volume>2</volume><elocation-id>e141</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0020141</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salery</surname><given-names>M</given-names></name><name><surname>Dos Santos</surname><given-names>M</given-names></name><name><surname>Saint-Jour</surname><given-names>E</given-names></name><name><surname>Moumné</surname><given-names>L</given-names></name><name><surname>Pagès</surname><given-names>C</given-names></name><name><surname>Kappès</surname><given-names>V</given-names></name><name><surname>Parnaudeau</surname><given-names>S</given-names></name><name><surname>Caboche</surname><given-names>J</given-names></name><name><surname>Vanhoutte</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Activity-regulated cytoskeleton-associated protein accumulates in the nucleus in response to cocaine and acts as a brake on chromatin remodeling and long-term behavioral alterations</article-title><source>Biological Psychiatry</source><volume>81</volume><fpage>573</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.05.025</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Multiple dopamine functions at different time courses</article-title><source>Annual Review of Neuroscience</source><volume>30</volume><fpage>259</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.28.061604.135722</pub-id><pub-id pub-id-type="pmid">17600522</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seamans</surname><given-names>JK</given-names></name><name><surname>Yang</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The principal features and mechanisms of dopamine modulation in the prefrontal cortex</article-title><source>Progress in Neurobiology</source><volume>74</volume><fpage>1</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2004.05.006</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Hawrylak</surname><given-names>VA</given-names></name><name><surname>Matus</surname><given-names>C</given-names></name><name><surname>Guido</surname><given-names>MA</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>2697</fpage><lpage>2708</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-07-02697.1998</pub-id><pub-id pub-id-type="pmid">9502827</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepherd</surname><given-names>JD</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>New views of Arc, a master regulator of synaptic plasticity</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1038/nn.2708</pub-id><pub-id pub-id-type="pmid">21278731</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigurdsson</surname><given-names>T</given-names></name><name><surname>Stark</surname><given-names>KL</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>Gordon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Impaired hippocampal–prefrontal synchrony in a genetic mouse model of schizophrenia</article-title><source>Nature</source><volume>464</volume><fpage>763</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1038/nature08855</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slifstein</surname><given-names>M</given-names></name><name><surname>van de Giessen</surname><given-names>E</given-names></name><name><surname>Van Snellenberg</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>JL</given-names></name><name><surname>Narendran</surname><given-names>R</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>Hackett</surname><given-names>E</given-names></name><name><surname>Girgis</surname><given-names>R</given-names></name><name><surname>Ojeil</surname><given-names>N</given-names></name><name><surname>Moore</surname><given-names>H</given-names></name><name><surname>D’Souza</surname><given-names>D</given-names></name><name><surname>Malison</surname><given-names>RT</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Lim</surname><given-names>K</given-names></name><name><surname>Nabulsi</surname><given-names>N</given-names></name><name><surname>Carson</surname><given-names>RE</given-names></name><name><surname>Lieberman</surname><given-names>JA</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia: a positron emission tomographic functional magnetic resonance imaging study</article-title><source>JAMA Psychiatry</source><volume>72</volume><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2414</pub-id><pub-id pub-id-type="pmid">25651194</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Modeling adolescent development and alcohol use in animals</article-title><source>Alcohol Research &amp; Health</source><volume>24</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">11199278</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Rewards, aversions and affect in adolescence: emerging convergences across laboratory animal and human data</article-title><source>Developmental Cognitive Neuroscience</source><volume>1</volume><fpage>392</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.dcn.2011.08.001</pub-id><pub-id pub-id-type="pmid">21918675</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sul</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Huh</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Distinct roles of rodent orbitofrontal and medial prefrontal cortex in decision making</article-title><source>Neuron</source><volume>66</volume><fpage>449</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.03.033</pub-id><pub-id pub-id-type="pmid">20471357</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sul</surname><given-names>JH</given-names></name><name><surname>Jo</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of rodent secondary motor cortex in value-based action selection</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>1202</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1038/nn.2881</pub-id><pub-id pub-id-type="pmid">21841777</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulzer</surname><given-names>D</given-names></name><name><surname>Cragg</surname><given-names>SJ</given-names></name><name><surname>Rice</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Striatal dopamine neurotransmission: regulation of release and uptake</article-title><source>Basal Ganglia</source><volume>6</volume><fpage>123</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.baga.2016.02.001</pub-id><pub-id pub-id-type="pmid">27141430</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamminga</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The neurobiology of cognition in schizophrenia</article-title><source>The Journal of Clinical Psychiatry</source><volume>67</volume><elocation-id>e11</elocation-id><pub-id pub-id-type="pmid">17081078</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tritsch</surname><given-names>NX</given-names></name><name><surname>Sabatini</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dopaminergic modulation of synaptic transmission in cortex and striatum</article-title><source>Neuron</source><volume>76</volume><fpage>33</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.023</pub-id><pub-id pub-id-type="pmid">23040805</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tropea</surname><given-names>D</given-names></name><name><surname>Hardingham</surname><given-names>N</given-names></name><name><surname>Millar</surname><given-names>K</given-names></name><name><surname>Fox</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms underlying the role of DISC1 in synaptic plasticity</article-title><source>The Journal of Physiology</source><volume>596</volume><fpage>2747</fpage><lpage>2771</lpage><pub-id pub-id-type="doi">10.1113/JP274330</pub-id><pub-id pub-id-type="pmid">30008190</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>KY</given-names></name><name><surname>O’Donnell</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dopamine modulation of prefrontal cortical interneurons changes during adolescence</article-title><source>Cerebral Cortex</source><volume>17</volume><fpage>1235</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhl034</pub-id><pub-id pub-id-type="pmid">16818475</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzschentke</surname><given-names>TM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Pharmacology and behavioral pharmacology of the mesocortical dopamine system</article-title><source>Progress in Neurobiology</source><volume>63</volume><fpage>241</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/s0301-0082(00)00033-2</pub-id><pub-id pub-id-type="pmid">11115727</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vander Weele</surname><given-names>CM</given-names></name><name><surname>Siciliano</surname><given-names>CA</given-names></name><name><surname>Matthews</surname><given-names>GA</given-names></name><name><surname>Namburi</surname><given-names>P</given-names></name><name><surname>Izadmehr</surname><given-names>EM</given-names></name><name><surname>Espinel</surname><given-names>IC</given-names></name><name><surname>Nieh</surname><given-names>EH</given-names></name><name><surname>Schut</surname><given-names>EHS</given-names></name><name><surname>Padilla-Coreano</surname><given-names>N</given-names></name><name><surname>Burgos-Robles</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>C-J</given-names></name><name><surname>Kimchi</surname><given-names>EY</given-names></name><name><surname>Beyeler</surname><given-names>A</given-names></name><name><surname>Wichmann</surname><given-names>R</given-names></name><name><surname>Wildes</surname><given-names>CP</given-names></name><name><surname>Tye</surname><given-names>KM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli</article-title><source>Nature</source><volume>563</volume><fpage>397</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0682-1</pub-id><pub-id pub-id-type="pmid">30405240</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayraghavan</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>SG</given-names></name><name><surname>Williams</surname><given-names>GV</given-names></name><name><surname>Arnsten</surname><given-names>AFT</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>376</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1038/nn1846</pub-id><pub-id pub-id-type="pmid">17277774</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>ND</given-names></name><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Croyle</surname><given-names>RT</given-names></name><name><surname>Bianchi</surname><given-names>DW</given-names></name><name><surname>Gordon</surname><given-names>JA</given-names></name><name><surname>Koroshetz</surname><given-names>WJ</given-names></name><name><surname>Pérez-Stable</surname><given-names>EJ</given-names></name><name><surname>Riley</surname><given-names>WT</given-names></name><name><surname>Bloch</surname><given-names>MH</given-names></name><name><surname>Conway</surname><given-names>K</given-names></name><name><surname>Deeds</surname><given-names>BG</given-names></name><name><surname>Dowling</surname><given-names>GJ</given-names></name><name><surname>Grant</surname><given-names>S</given-names></name><name><surname>Howlett</surname><given-names>KD</given-names></name><name><surname>Matochik</surname><given-names>JA</given-names></name><name><surname>Morgan</surname><given-names>GD</given-names></name><name><surname>Murray</surname><given-names>MM</given-names></name><name><surname>Noronha</surname><given-names>A</given-names></name><name><surname>Spong</surname><given-names>CY</given-names></name><name><surname>Wargo</surname><given-names>EM</given-names></name><name><surname>Warren</surname><given-names>KR</given-names></name><name><surname>Weiss</surname><given-names>SRB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The conception of the ABCD study: From substance use to a broad NIH collaboration</article-title><source>Developmental Cognitive Neuroscience</source><volume>32</volume><fpage>4</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.dcn.2017.10.002</pub-id><pub-id pub-id-type="pmid">29051027</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>DM</given-names></name><name><surname>Bell</surname><given-names>MR</given-names></name><name><surname>Flores</surname><given-names>C</given-names></name><name><surname>Gulley</surname><given-names>JM</given-names></name><name><surname>Willing</surname><given-names>J</given-names></name><name><surname>Paul</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adolescence and reward: Making sense of neural and behavioral changes amid the chaos</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>10855</fpage><lpage>10866</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1834-17.2017</pub-id><pub-id pub-id-type="pmid">29118215</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KH</given-names></name><name><surname>Majewska</surname><given-names>A</given-names></name><name><surname>Schummers</surname><given-names>J</given-names></name><name><surname>Farley</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Sur</surname><given-names>M</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex</article-title><source>Cell</source><volume>126</volume><fpage>389</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.06.038</pub-id><pub-id pub-id-type="pmid">16873068</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Williams</surname><given-names>PR</given-names></name><name><surname>Alwahab</surname><given-names>NSA</given-names></name><name><surname>Kapur</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Gerfen</surname><given-names>CR</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name><name><surname>He</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Deconstruction of corticospinal circuits for goal-directed motor skills</article-title><source>Cell</source><volume>171</volume><fpage>440</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.08.014</pub-id><pub-id pub-id-type="pmid">28942925</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watabe-Uchida</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Ogawa</surname><given-names>SK</given-names></name><name><surname>Vamanrao</surname><given-names>A</given-names></name><name><surname>Uchida</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Whole-brain mapping of direct inputs to midbrain dopamine neurons</article-title><source>Neuron</source><volume>74</volume><fpage>858</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.03.017</pub-id><pub-id pub-id-type="pmid">22681690</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinstein</surname><given-names>JJ</given-names></name><name><surname>Chohan</surname><given-names>MO</given-names></name><name><surname>Slifstein</surname><given-names>M</given-names></name><name><surname>Kegeles</surname><given-names>LS</given-names></name><name><surname>Moore</surname><given-names>H</given-names></name><name><surname>Abi-Dargham</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Pathway-specific dopamine abnormalities in schizophrenia</article-title><source>Biological Psychiatry</source><volume>81</volume><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.03.2104</pub-id><pub-id pub-id-type="pmid">27206569</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Z</given-names></name><name><surname>Nguyen</surname><given-names>HN</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Lalli</surname><given-names>MA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>N-S</given-names></name><name><surname>Yoon</surname><given-names>K-J</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Makri</surname><given-names>G</given-names></name><name><surname>Nauen</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Guzman</surname><given-names>E</given-names></name><name><surname>Chiang</surname><given-names>C-H</given-names></name><name><surname>Yoritomo</surname><given-names>N</given-names></name><name><surname>Kaibuchi</surname><given-names>K</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Christian</surname><given-names>KM</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Margolis</surname><given-names>RL</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Kosik</surname><given-names>KS</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Ming</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Synaptic dysregulation in a human iPS cell model of mental disorders</article-title><source>Nature</source><volume>515</volume><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1038/nature13716</pub-id><pub-id pub-id-type="pmid">25132547</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Moghaddam</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs</article-title><source>The Journal of Neuroscience</source><volume>32</volume><fpage>3022</fpage><lpage>3031</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6377-11.2012</pub-id><pub-id pub-id-type="pmid">22378875</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Y</given-names></name><name><surname>Mastwal</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>VY</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Elkahloun</surname><given-names>AG</given-names></name><name><surname>Wang</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dopamine is required for activity-dependent amplification of Arc mRNA in developing postnatal frontal cortex</article-title><source>Cerebral Cortex</source><volume>27</volume><fpage>3600</fpage><lpage>3608</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw181</pub-id><pub-id pub-id-type="pmid">27365296</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yizhar</surname><given-names>O</given-names></name><name><surname>Fenno</surname><given-names>LE</given-names></name><name><surname>Prigge</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>F</given-names></name><name><surname>Davidson</surname><given-names>TJ</given-names></name><name><surname>O’Shea</surname><given-names>DJ</given-names></name><name><surname>Sohal</surname><given-names>VS</given-names></name><name><surname>Goshen</surname><given-names>I</given-names></name><name><surname>Finkelstein</surname><given-names>J</given-names></name><name><surname>Paz</surname><given-names>JT</given-names></name><name><surname>Stehfest</surname><given-names>K</given-names></name><name><surname>Fudim</surname><given-names>R</given-names></name><name><surname>Ramakrishnan</surname><given-names>C</given-names></name><name><surname>Huguenard</surname><given-names>JR</given-names></name><name><surname>Hegemann</surname><given-names>P</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neocortical excitation/inhibition balance in information processing and social dysfunction</article-title><source>Nature</source><volume>477</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1038/nature10360</pub-id><pub-id pub-id-type="pmid">21796121</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Ward</surname><given-names>MD</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Chuang</surname><given-names>Y-A</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Leahy</surname><given-names>DJ</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural basis of arc binding to synaptic proteins: implications for cognitive disease</article-title><source>Neuron</source><volume>86</volume><fpage>490</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.030</pub-id><pub-id pub-id-type="pmid">25864631</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87414.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>West</surname><given-names>Anne E</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Duke University</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This is an <bold>important</bold> study that addresses the interesting question of whether stimulation of DA input to prefrontal cortex during adolescence can be used to rescue genetic defects on DA regulation of PFC function. The conclusions are <bold>convincingly</bold> supported by the data together with discussion of some limitations of the approach. This story will of interest to a broad group of neuroscientists interested in regulation of prefrontal cortical function in behavior.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87414.3.sa1</article-id><title-group><article-title>Joint Public Review:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors have previously established that activation of dopamine inputs to prefrontal cortex during adolescence can drive increases in mPFC DA bouton number and enhanced mPFC activity in WT mice. The current study was designed to test the hypothesis that neural circuit plasticity during adolescence can be targeted to restore cortical function under conditions of developmental disruptions that are relevant to psychiatric disorders.</p><p>Specifically, the manuscript explores how transient adolescent stimulation of ventral midbrain neurons that project to the frontal cortex may help to improve performance on certain memory tasks. The authors used DREADDs to regulate the mesofrontal cortical dopamine system in two mouse models - one with a reporter replacing the Arc gene, and another with knockout of the schizophrenia-associated gene Disc1, both of which are thought to have reduced prefrontal cortical activity. The manuscript provides an interesting set of observations that DREADD-based activation over only 3 days during adolescence provides a fast-acting and long-lasting improvement in performance on Y-maze spontaneous alternation as well as aspects of neuronal function as assessed using in vivo imaging methods.</p><p>A strength of this study is that the authors performed key manipulations using age and dose/intensity as dependent variables to show that the level of neural circuit activation during adolescence follows an inverted U-shape pattern, though the precise postsynaptic mechanisms underlying the positive impact of adolescent mesofrontal dopamine neuron stimulation were not addressed.</p><p>One limitation discussed by the reviewers is that using TH-Cre mice (as compared with DAT-Cre) to drive transgene expression in VTA neurons could lead to expression outside the dopaminergic population of neurons, though in the revision the authors have provided additional lines of evidence to support their model of dopamine regulation of frontal cortex in this study.</p><p>Collectively, this is a well-design study with many strengths and novel findings that are likely to positively impact a widespread of disciplines within the biological psychiatry and neuroscience field.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.87414.3.sa2</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mastwal</surname><given-names>Surjeet</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute of Mental Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xinjian</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute of Mental Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Stowell</surname><given-names>Rianne</given-names></name><role specific-use="author">Author</role><aff><institution>University of Rochester Medical Center</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Manion</surname><given-names>Matthew</given-names></name><role specific-use="author">Author</role><aff><institution>National Institute of Mental Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wenyu</given-names></name><role specific-use="author">Author</role><aff><institution>University of Rochester Medical Center</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Nam-Shik</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Ki-Jun</given-names></name><role specific-use="author">Author</role><aff><institution>KAIST</institution><addr-line><named-content content-type="city">Deajeon</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Song</surname><given-names>Hongjun</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ming</surname><given-names>Guo-Li</given-names></name><role specific-use="author">Author</role><aff><institution>Perelman School of Medicine at the University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Kuan Hong</given-names></name><role specific-use="author">Author</role><aff><institution>University of Rochester Medical Center</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><p>First and foremost, we would like to thank all the editors and reviewers for their thoughtful and thorough evaluations of our manuscript. We greatly appreciate their assessment about the novelty and strength in this study and have revised the manuscript according to their recommendations. Below are our detailed responses and revisions based on the reviewer recommendations.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p><p>1. It is unclear the rationale for choosing the P35-42 adolescent window for stimulating the mesofrontal dopamine system.</p></disp-quote><p>The dopaminergic innervation in the mesofrontal circuit exhibits a protracted maturation from P21 to P56 (Kalsbeek, Voorn et al. 1988, Niwa, Kamiya et al. 2010, Naneix, Marchand et al. 2012, Hoops and Flores 2017). P35-42 is in the center of this period and captures the mid-adolescent stage in rodents (Spear 2000). We have previously shown that increasing dopamine neuron activity by wheel running or optogenetic stimulation during this period, but not adulthood, can induce formation of mesofrontal dopaminergic boutons and enhance mesofrontal circuit activity in wild-type mice (Mastwal, Ye et al. 2014). We therefore chose the P35-P42 adolescent window to stimulate the mesofrontal dopamine circuit and test the long-term effect of this intervention on the frontal circuit and memory-guided decision-making deficits in mutant mice. We have detailed this rationale in the revised manuscript when we first introduced this intervention.</p><disp-quote content-type="editor-comment"><p>2). Please provide a justification for choosing the optical recording M2 neuronal activity instead of the prelimbic prefrontal cortex, which has been known to show the highest levels of dopamine terminals.</p></disp-quote><p>While the prelimbic area has the highest level of dopamine terminals among frontal cortical regions, a robust presence of dopaminergic terminals and dopamine release in the M2 frontal cortex have been well documented (Berger, Gaspar et al. 1991, Mastwal, Ye et al. 2014, Aransay, Rodriguez-Lopez et al. 2015, Patriarchi, Cho et al. 2018). The M2 cortex plays an important role in action planning, generating the earliest neural signals among frontal cortical regions that are related to upcoming choice during spatial navigation (Sul, Kim et al. 2010, Sul, Jo et al. 2011). Our chemogenetic inactivation experiments (Supplementary Fig 1) has further confirmed the involvement of M2 in the memory-guided Y-maze navigation task used in this study. Technically, M2 has the advantage of being more amendable to optical recording of neuronal activity without the tissue damage caused by implanting a lens, which would be necessary for deeper areas such as the prelimbic cortex. We have provided this justification in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3). What was the rationale for using the 3-day chemogenetic stimulation paradigm?</p></disp-quote><p>Our previous work in wild-type adolescent mice showed that a single optogenetic stimulation session or a 2-hr wheel running session is sufficient to induce bouton formation in mesofrontal dopaminergic axons (Mastwal, Ye et al. 2014). In this study, we sought to rescue existing structural and functional deficits in the mesofrontal dopaminergic circuits due to genetic mutations. Because previous studies suggested that an optimal level of dopamine is important for normal cognitive function (Arnsten, Cai et al. 1994, Robbins 2000, Floresco 2013), we elected to do multiple stimulation sessions to boost the potential rescue effects. We tested both a 3-day and a 3-week stimulation paradigm, and found that the 3-day, but not the 3-week paradigm led to robust functional improvement (Fig. 5). These results indicate that moderate but not excessive stimulation of dopamine neurons can provide functional improvement of a deficient mesofrontal circuit. We have revised our text to clarify the rationale for these experiments.</p><disp-quote content-type="editor-comment"><p>4). A major maturational event occurring in the prefrontal cortex is the gain of local GABAergic transmission, which is crucial for sustaining proper levels of Y-maze tasks. I am wondering if the authors have any thoughts about what is really happening at the postsynaptic level following adolescent dopamine stimulation.</p></disp-quote><p>The developmental increases in dopaminergic innervation to the frontal cortex and local GABAergic transmission are likely synergistic processes, which both contribute to the maturation of high-order cognitive functions supported by the frontal cortex (Caballero and Tseng 2016, Larsen and Luna 2018). Previous electrophysiological studies have suggested that dopamine can act on five different receptors expressed in both excitatory and inhibitory postsynaptic neurons (Seamans and Yang 2004, Tseng and O'Donnell 2007, O'Donnell 2010). At the network level, dopaminergic signaling can increase the signal-to-noise ratio and temporal synchrony of neural activity during cognitive tasks (Rolls, Loh et al. 2008, Vander Weele, Siciliano et al. 2018, Lohani, Martig et al. 2019). As the frontal GABAergic inhibitory network undergoes major functional remodeling during adolescence (Caballero and Tseng 2016), adolescent stimulation of dopamine neurons may interact with this maturational process to promote a network configuration conducive for synchronous and high signal-to-noise neural computation (Porter, Rizzo et al. 1999, Murty, Calabro et al. 2016, Mukherjee, Carvalho et al. 2019). The microcircuit mechanisms underlying adolescent dopamine stimulation induced changes, particularly in the GABAergic inhibitory neurons, will be an exciting direction for future research. We have extended our discussion about these points in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>5). A change in the density of dopamine boutons is unlikely to be limited to the M2 region in Arc-/- mice. The authors should provide some data illustrating that similar changes are widespread across the medial prefrontal cortex, and that the optical recording in the M2 region was preferred for technical limitations and to avoid damaging areas in the frontal cortex.</p></disp-quote><p>As discussed above, this study focused on the M2 region of the frontal cortex because it is functionally required for memory-guided Y-maze navigation, generates behavioral choice-related neural signals during spatial navigation, and is optically most accessible. The medial prefrontal regions (anterior cingulate, prelimbic and infralimbic) ventral to M2 also receive dense dopaminergic innervation and can act in concert with M2 in decision making (Sul, Kim et al. 2010, Sul, Jo et al. 2011, Barthas and Kwan 2017). As dopaminergic innervations to the frontal cortical regions progress in a ventral-to-dorsal direction during development (Kalsbeek, Voorn et al. 1988, Hoops and Flores 2017), how the changes induced by adolescent dopamine stimulation may proceed spatial-temporally across different frontal subregions requires more extensive investigation in the future. We have added this discussion into the revised manuscript.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public Review):</bold></p><p>The manuscript by Mastwal and colleagues explores how transient adolescent stimulation of ventral midbrain neurons that project to the frontal cortex may help to improve performance on certain memory tasks. The manuscript provides an interesting set of observations that DREADD-based activation over only 3 days during adolescence provides a fast-acting and long-lasting improvement in performance on Y-maze spontaneous alternation as well as aspects of neuronal function as assessed using in vivo imaging methods. While interesting, there are several weaknesses. First and foremost, it is not clear that the effects the authors are observing are mediated by dopamine. It has been clearly documented that the DAT-Cre line provides a better representation of midbrain dopamine cells in the mouse, particularly near the midline of the ventral midbrain (Lammel et al., Neuron 2015). This is precisely where the cells that project to the frontal cortex are located. Therefore, the selection of TH-Cre is problematic. It is very likely that the authors are labeling a substantial number of non-dopaminergic cells.</p></disp-quote><p>We agree with Review 2 that the DAT-Cre line can provide specific labeling of midbrain dopamine neurons, particularly those projecting to the striatum, as discussed in the cited study (Lammel, Steinberg et al. 2015). DAT transports the extracellularly released dopamine back into presynaptic terminals, but it is not essential for dopamine synthesis and release (Sulzer, Cragg et al. 2016). Mesocortical dopamine neurons in the ventral tegmental area (VTA) express very little DAT (Sesack, Hawrylak et al. 1998, Lammel, Hetzel et al. 2008, Li, Qi et al. 2013), which limits the use of the DAT-Cre line to target these neurons (Lammel, Steinberg et al. 2015). Because mesocortical dopamine neurons have strong expression of TH, a key enzyme involved in dopamine synthesis, TH-Cre lines have been extensively used to study the mesocortical pathway (Lammel, Lim et al. 2012, Gunaydin, Grosenick et al. 2014, Ellwood, Patel et al. 2017, Vander Weele, Siciliano et al. 2018, Lohani, Martig et al. 2019). We provide more details below about our rationales for using TH-Cre rather than DAT-Cre mice in our study and the revisions we made in response to the reviewer’s specific recommendations.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p><p>1). The authors should rigorously demonstrate that there is a reasonable midbrain DA projection to the coordinates that they are assessing and that their effects are due to DA release from these cells. It is not clear that there is a VTA dopaminergic projection to M2 - it does not appear for example in the Allen Mouse Brain Connectivity Atlas (<ext-link ext-link-type="uri" xlink:href="https://connectivity.brainmap.org/projection/experiment/siv/160540751">https://connectivity.brainmap.org/projection/experiment/siv/160540751</ext-link>? imageId=160541123&amp;imageType=TWO_PHOTON,SEGMENTATION&amp;initImage=TWO_PHOTON&amp;x=17321&amp;y=15284&amp;z=3). Though there is a projection to the mPFC, at the coordinates the authors report, there does not appear to be any signal from DAT-Cre mice. However, there is much more signal when expression is not restricted to dopamine cells (<ext-link ext-link-type="uri" xlink:href="https://connectivity.brain-map.org/projection/experiment/siv/165975096">https://connectivity.brain-map.org/projection/experiment/siv/165975096</ext-link>? imageId=165975158&amp;imageType=TWO_PHOTON,SEGMENTATION&amp;initImage=TWO_PHOTON&amp;x=17950&amp;y=11504&amp;z=3). The argument that these cells may express less TH is not relevant for this particular issue. Therefore, it is possible that the vast majority of observed effects are not in fact mediated by dopamine but another neurotransmitter such as glutamate. While the experiment using SCH23390 does suggest DA receptors may be involved, this result in isolation doesn't alleviate this caveat - there can be, for example, DA release from NE cells (e.g., Takeuchi et al., Nature 2016). While this does not entirely invalidate the authors' results, as their effects of stimulation of ventral midbrain cells to the forebrain don't necessarily have to occur via dopamine - the mechanism by how this is occurring needs to be clear.</p></disp-quote><p>While the prelimbic area has the highest level of dopaminergic terminals among frontal cortical regions, a robust presence of midbrain dopaminergic projections and dopamine release in the M2 frontal cortex have been well established by immunostaining, viral labeling, single-cell axon-tracing, and in vivo imaging of recently developed dopamine biosensors (Berger, Gaspar et al. 1991, Mastwal, Ye et al. 2014, Aransay, Rodriguez-Lopez et al. 2015, Ye, Mastwal et al. 2017, Patriarchi, Cho et al. 2018). It has also been reported repeatedly that mesocortical dopamine neurons in the VTA express very little DAT, which is different from mesostriatal dopamine neurons (Sesack, Hawrylak et al. 1998, Lammel, Hetzel et al. 2008, Li, Qi et al. 2013). This limitation in the use of the DAT-Cre line to target mesocortical dopamine neurons has been acknowledged in previous studies (Lammel, Steinberg et al. 2015) and is consistent with the reviewer’s observation of DAT-Cre labeling in the Allen Brain Mouse Connectivity atlas. Additionally, and interestingly, recent extensive evaluation of the DAT-Cre line reported ectopic labeling of multiple non-dopaminergic neuronal populations (Soden, Miller et al. 2016, Stagkourakis, Spigolon et al. 2018, Papathanou, Dumas et al. 2019). Our own evaluation of the DAT-Cre line’s utility for cortical imaging also revealed sparse axonal labeling and sporadic ectopic labeling of cortical cell somas. We have included representative DAT-Cre images in Author response image 1 to highlight the limitations of this line in the study of the dopaminergic mesocortical circuit.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Example images from DAT-Cre/Ai14 mice.</title><p>Left most panel shows little axonal labeling in Layer 5/6 of M2. The center panel shows sparse axonal label in Layer 1/2 of M2, but also ectopic labeling of cell soma. The right panel shows a lack of labeling in L1/2 of prelimbic cortex as well. Scale bars 50um.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-87414-sa2-fig1-v1.tif"/></fig><p>We as well as others have confirmed that TH immunoreactivity in the frontal cortex can label dopaminergic axons originated from the VTA, and ablation of VTA dopaminergic neurons removes this labeling (Niwa, Jaaro-Peled et al. 2013, Ye, Mastwal et al. 2017). Because mesocortical dopamine neurons have much stronger TH expression than DAT expression (Sesack, Hawrylak et al. 1998, Lammel, Hetzel et al. 2008, Li, Qi et al. 2013, Lammel, Steinberg et al. 2015), TH-Cre lines have been frequently used to label these neurons and study the mesocortical pathway (Lammel, Lim et al. 2012, Gunaydin, Grosenick et al. 2014, Ellwood, Patel et al. 2017, Vander Weele, Siciliano et al. 2018, Lohani, Martig et al. 2019). While TH-Cre expression itself is not restricted to dopaminergic neurons, we targeted our viral injections to the VTA and optogenetic stimulation to the cortical dopaminergic projection target area in M2 (Patriarchi, Cho et al. 2018) to specifically modulate mesofrontal dopaminergic axons. In addition, we tested D1 antagonist’s effects in our manipulations. Although we targeted dopamine neurons in our adolescent stimulation, the final behavioral outcome likely includes contributions from co-released neurotransmitters such as glutamate and non-dopaminergic neurons via network effects (Morales and Margolis 2017, Lohani, Martig et al. 2019), which will be interesting directions for future research. We have revised our results and discussion sections to highlight our rationales for using the TH-Cre line and the open mechanistic questions for future studies.</p><disp-quote content-type="editor-comment"><p>1. SSFOs don't increase excitability like DREADDs, but rather, cause long-lasting hyperactivity through continuous passage of cations. What the actual firing properties are of these cells over a long period of time is not clear.</p></disp-quote><p>We did not measure the precise firing patterns of the dopaminergic neurons targeted by SSFOs but evaluated the effects of SSFO activation on the frontal cortex. Similar to our DREADD-Gq mediated activity changes in the mesofrontal circuit, we found increased frontal cortical activity post-light stimulation of frontal dopamine axons in our SSFO treated animals (Fig 6a-c, S6e). While quantitatively the firing patterns of DREADD-Gq and SSFO activated dopaminergic neurons likely differ, qualitatively both of these manipulations lead to increased mesofrontal circuit activity and improvements in cognitive behaviors. In our previous work with wild-type adolescent mice, both wheel running and a single 10-min session of phasic optogenetic stimulation of the VTA resulted in dopaminergic bouton outgrowth in the frontal cortex (Mastwal, Ye et al. 2014). Taken together, these results suggest that adolescent dopaminergic mesofrontal projections are highly responsive to neural activity changes and a variety of adolescent stimulation paradigms are sufficient to elicit lasting changes in this circuit. We have added this discussion of the limitations and implications of our study into the revised manuscript.</p><disp-quote content-type="editor-comment"><p>1. It is not clear what the increase in boutons means, given that DA release is thought to largely occur via non-synaptic release.</p></disp-quote><p>Although many of dopamine boutons are not associated with defined postsynaptic structures, these axonal boutons and the active zones they contain are the major release sites for dopamine (Goldman-Rakic, Leranth et al. 1989, Arbuthnott and Wickens 2007, Sulzer, Cragg et al. 2016, Liu, Goel et al. 2021). Past studies have established a consistent association between increased dopaminergic innervation in the frontal cortex and an increase in dopamine levels (Niwa, Kamiya et al. 2010, Naneix, Marchand et al. 2012). Our previous work also found that increasing dopaminergic boutons through adolescent VTA stimulation led to prolonged frontal local field potential responses with high-frequency oscillations (Mastwal, Ye et al. 2014), which is characteristic of increased dopaminergic signaling (Lewis and O'Donnell 2000, Gireesh and Plenz 2008, Wood, Kim et al. 2012, Lohani, Martig et al. 2019). Importantly, in our quantification of the structural changes in this study, we evaluated boutons which were labeled with synaptophysin, a molecular marker indicating the presence of synaptic vesicle release machinery (Li, Tasic et al. 2010, Oh, Harris et al. 2014). Thus, our study, taken in the context of the previous work, suggests the increased number of boutons signifying an increase in dopaminergic signaling within the mesofrontal circuit. We have added this discussion into the revised manuscript.</p><disp-quote content-type="editor-comment"><p>1. The use of Arc and DISC mutants as models of schizophrenia is perhaps a bit overstated - while deficits in prefrontal innervation certainly occur, there are many differences between these models and the human disease states. Language should be toned down accordingly, particularly in the introduction.</p></disp-quote><p>We strived to avoid overstating the extent to which the mouse lines are models for specific diseases, but we can appreciate that this may not have been clear in our original writing. We have adjusted our language to better distinguish between the utility of the animal models for the purposes of our study and their relationship to specific human disease states. Particularly in the introduction, we stated that: “Genetic disruptions of several genes involved in synaptic functions related to psychiatric disorders, such as Arc and DISC1, lead to hypoactive mesofrontal dopaminergic input in mice (Niwa, Kamiya et al. 2010, Niwa, Jaaro-Peled et al. 2013, Fromer, Pocklington et al. 2014, Purcell, Moran et al. 2014, Wen, Nguyen et al. 2014, Manago, Mereu et al. 2016). Although there are many differences between these mouse lines and specific human disease states, these mice offer opportunities to test whether genetic deficits in frontal cortex function can be reversed through circuit interventions.”</p><disp-quote content-type="editor-comment"><p>1. Some experiments are missing proper controls, e.g., Figure 3g-I where a WT mouse should be used as a positive control.</p></disp-quote><p>The goal of this experimental design (Fig 3g-i) was to evaluate the potential effects of chemogenetic VTA stimulation in the Arc-/- mice. We used Arc-/- mice with mCherry injections to control for the potential effects of CNO administration. While WT mice could be used to determine if adolescent VTA stimulation would lead to long-lasting enhancement of VTA-to-Cortical transmission, this wouldn’t necessarily be a positive control for our experiments, but rather a separate line of inquiry. As dopamine’s effects often display an inverted-U dose-response curve (Vijayraghavan, Wang et al. 2007, Floresco 2013), evaluating the effects adolescent VTA stimulation in the absence of underlying dopamine deficiency could be an interesting future research direction. We have added this discussion into the revised manuscript.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations For The Authors):</bold></p><p>1. Did the SSFO stimulation of the TH+ axons in PFC during adolescence lead to the same long-term change in DA bouton number the authors saw with DREADDs?</p></disp-quote><p>We did not examine the degree of bouton growth in the SSFO cohort, which is a limitation of this study. Accurate quantification of dopamine boutons requires the co-injection of another AAV vector encoding Synaptophysin-GFP to label the boutons. Because we used light to directly stimulate SSFO-labeled dopaminergic axons in the frontal cortex, we were concerned that co-injecting another AAV vector may dilute SSFO-labeling of axons and reduce the efficacy of optogenetic stimulation. Given the behavioral benefits we observed, we would expect an increase in bouton density after optogenetic stimulation. A systematic optimization of viral co-labeling and optogenetic stimulation protocols will facilitate examination of the impact of SSFO stimulation at the structural level in future studies. We have added a discussion of the limitation of this study in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>1. The DISC1 section is far less detailed than the Arc section, and it was not completely clear to me that the mechanisms of dysfunction and rescue were the same in these mice compared with the Arc mice. For example, there was no mention of DA bouton density or the patterned firing of the PFC neurons at the time of decision making.</p></disp-quote><p>The initial motivation of this study was to test if adolescent dopamine stimulation can rescue the deficits in the mesofrontal dopaminergic circuit and cognitive function of Arc-/- mice, which were identified in our previous studies (Manago, Mereu et al. 2016). We first conducted multiple levels of analyses including viral tracing, in vivo calcium imaging, and behavioral tests to establish the coherent impacts of adolescent dopamine neuron stimulation on circuits and behaviors. We then examined a range of stimulation protocols to assess the efficacy requirements for cognitive improvement, which is our primary goal. Finally, we included DISC1 mice in our study to test if adolescent dopamine stimulation can also reverse the cognitive deficit in another genetic model for mesofrontal dopamine deficiency. By demonstrating a similar cognitive recuse effect of adolescent VTA stimulation in an independent mouse model, this study provides a foundation for future research to compare the detailed cellular mechanisms that underlie the functional rescue in different genetic models. We have added the discussion of the scope and limitation of this study to the revised manuscript.</p><p>References</p><p>Aransay, A., C. Rodriguez-Lopez, M. Garcia-Amado, F. Clasca and L. Prensa (2015). &quot;Long-range projection neurons of the mouse ventral tegmental area: a single-cell axon tracing analysis.&quot; Front Neuroanat 9: 59.</p><p>Arbuthnott, G. W. and J. Wickens (2007). &quot;Space, time and dopamine.&quot; Trends Neurosci 30(2): 62-69.</p><p>Arnsten, A. F., J. X. Cai, B. L. Murphy and P. S. Goldman-Rakic (1994). &quot;Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.&quot; Psychopharmacology (Berl) 116(2): 143-151.</p><p>Barthas, F. and A. C. Kwan (2017). &quot;Secondary motor cortex: where ‘sensory’meets ‘motor’in the rodent frontal cortex.&quot; Trends in neurosciences 40(3): 181-193.</p><p>Berger, B., P. Gaspar and C. Verney (1991). &quot;Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.&quot; Trends Neurosci 14(1): 21-27.</p><p>Caballero, A. and K. Y. Tseng (2016). &quot;GABAergic Function as a Limiting Factor for Prefrontal Maturation during Adolescence.&quot; Trends Neurosci 39(7): 441-448.</p><p>Ellwood, I. T., T. Patel, V. Wadia, A. T. Lee, A. T. Liptak, K. J. Bender and V. S. Sohal (2017). &quot;Tonic or Phasic Stimulation of Dopaminergic Projections to Prefrontal Cortex Causes Mice to Maintain or Deviate from Previously Learned Behavioral Strategies.&quot; J Neurosci 37(35): 8315-8329.</p><p>Floresco, S. B. (2013). &quot;Prefrontal dopamine and behavioral flexibility: shifting from an &quot;inverted-U&quot; toward a family of functions.&quot; Front Neurosci 7: 62.</p><p>Fromer, M., A. J. Pocklington, D. H. Kavanagh, H. J. Williams, S. Dwyer, P. Gormley, L. Georgieva, E. Rees, P. Palta, D. M. Ruderfer, N. Carrera, I. Humphreys, J. S. Johnson, P. Roussos, D. D. Barker, E. Banks, V. Milanova, S. G. Grant, E. Hannon, S. A. Rose, K. Chambert, M. Mahajan, E. M. Scolnick, J. L. Moran, G. Kirov, A. Palotie, S. A. McCarroll, P. Holmans, P. Sklar, M. J. Owen, S. M. Purcell and M. C. O'Donovan (2014). &quot;De novo mutations in schizophrenia implicate synaptic networks.&quot; Nature 506(7487): 179-184.</p><p>Gireesh, E. D. and D. Plenz (2008). &quot;Neuronal avalanches organize as nested theta- and beta/gamma-oscillations during development of cortical layer 2/3.&quot; Proc Natl Acad Sci U S A 105(21): 7576-7581.</p><p>Goldman-Rakic, P. S., C. Leranth, S. M. Williams, N. Mons and M. Geffard (1989). &quot;Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex.&quot; Proc Natl Acad Sci U S A 86(22): 9015-9019.</p><p>Gunaydin, L. A., L. Grosenick, J. C. Finkelstein, I. V. Kauvar, L. E. Fenno, A. Adhikari, S. Lammel, J. J. Mirzabekov, R. D. Airan, K. A. Zalocusky, K. M. Tye, P. Anikeeva, R. C. Malenka and K. Deisseroth (2014). &quot;Natural neural projection dynamics underlying social behavior.&quot; Cell 157(7): 1535-1551.</p><p>Hoops, D. and C. Flores (2017). &quot;Making Dopamine Connections in Adolescence.&quot; Trends Neurosci 40(12): 709-719.</p><p>Kalsbeek, A., P. Voorn, R. M. Buijs, C. W. Pool and H. B. Uylings (1988). &quot;Development of the dopaminergic innervation in the prefrontal cortex of the rat.&quot; J Comp Neurol 269(1): 58-72.</p><p>Lammel, S., A. Hetzel, O. Hackel, I. Jones, B. Liss and J. Roeper (2008). &quot;Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system.&quot; Neuron 57(5): 760-773.</p><p>Lammel, S., A. Hetzel, O. Haeckel, I. Jones, B. Liss and J. Roeper (2008). &quot;Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system.&quot; Neuron 57(5): 760-773.</p><p>Lammel, S., B. K. Lim, C. Ran, K. W. Huang, M. J. Betley, K. M. Tye, K. Deisseroth and R. C. Malenka (2012). &quot;Input-specific control of reward and aversion in the ventral tegmental area.&quot; Nature 491(7423): 212-217.</p><p>Lammel, S., E. E. Steinberg, C. Foldy, N. R. Wall, K. Beier, L. Luo and R. C. Malenka (2015). &quot;Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons.&quot; Neuron 85(2): 429-438.</p><p>Larsen, B. and B. Luna (2018). &quot;Adolescence as a neurobiological critical period for the development of higher-order cognition.&quot; Neurosci Biobehav Rev 94: 179-195.</p><p>Lewis, B. L. and P. O'Donnell (2000). &quot;Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors.&quot; Cereb Cortex 10(12): 1168-1175.</p><p>Li, L., B. Tasic, K. D. Micheva, V. M. Ivanov, M. L. Spletter, S. J. Smith and L. Luo (2010). &quot;Visualizing the distribution of synapses from individual neurons in the mouse brain.&quot; PLoS One 5(7): e11503.</p><p>Li, X., J. Qi, T. Yamaguchi, H. L. Wang and M. Morales (2013). &quot;Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.&quot; Brain Struct Funct 218(5): 1159-1176.</p><p>Liu, C., P. Goel and P. S. Kaeser (2021). &quot;Spatial and temporal scales of dopamine transmission.&quot; Nat Rev Neurosci 22(6): 345-358.</p><p>Lohani, S., A. K. Martig, K. Deisseroth, I. B. Witten and B. Moghaddam (2019). &quot;Dopamine Modulation of Prefrontal Cortex Activity Is Manifold and Operates at Multiple Temporal and Spatial Scales.&quot; Cell Rep 27(1): 99-114 e116.</p><p>Manago, F., M. Mereu, S. Mastwal, R. Mastrogiacomo, D. Scheggia, M. Emanuele, M. A. De Luca, D. R. Weinberger, K. H. Wang and F. Papaleo (2016). &quot;Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.&quot; Cell Rep 16(8): 2116-2128.</p><p>Mastwal, S., Y. Ye, M. Ren, D. V. Jimenez, K. Martinowich, C. R. Gerfen and K. H. Wang (2014). &quot;Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence.&quot; J Neurosci 34(29): 9484-9496.</p><p>Morales, M. and E. B. Margolis (2017). &quot;Ventral tegmental area: cellular heterogeneity, connectivity and behaviour.&quot; Nat Rev Neurosci 18(2): 73-85.</p><p>Mukherjee, A., F. Carvalho, S. Eliez and P. Caroni (2019). &quot;Long-Lasting Rescue of Network and Cognitive Dysfunction in a Genetic Schizophrenia Model.&quot; Cell 178(6): 1387-1402 e1314.Murty, V. P., F. Calabro and B. Luna (2016). &quot;The role of experience in adolescent cognitive development: Integration of executive, memory, and mesolimbic systems.&quot; Neurosci Biobehav Rev 70: 46-58.</p><p>Naneix, F., A. R. Marchand, G. Di Scala, J. R. Pape and E. Coutureau (2012). &quot;Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence.&quot; J Neurosci 32(46): 16223-16232.</p><p>Niwa, M., H. Jaaro-Peled, S. Tankou, S. Seshadri, T. Hikida, Y. Matsumoto, N. G. Cascella, S. Kano, N. Ozaki, T. Nabeshima and A. Sawa (2013). &quot;Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.&quot; Science 339(6117): 335-339.</p><p>Niwa, M., A. Kamiya, R. Murai, K. Kubo, A. J. Gruber, K. Tomita, L. Lu, S. Tomisato, H. Jaaro-Peled, S. Seshadri, H. Hiyama, B. Huang, K. Kohda, Y. Noda, P. O'Donnell, K. Nakajima, A. Sawa and T. Nabeshima (2010). &quot;Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits.&quot; Neuron 65(4): 480-489.</p><p>O'Donnell, P. (2010). &quot;Adolescent maturation of cortical dopamine.&quot; Neurotox Res 18(3-4): 306-312.</p><p>Oh, S. W., J. A. Harris, L. Ng, B. Winslow, N. Cain, S. Mihalas, Q. Wang, C. Lau, L. Kuan, A. M. Henry, M. T. Mortrud, B. Ouellette, T. N. Nguyen, S. A. Sorensen, C. R. Slaughterbeck, W. Wakeman, Y. Li, D. Feng, A. Ho, E. Nicholas, K. E. Hirokawa, P. Bohn, K. M. Joines, H. Peng, M. J. Hawrylycz, J. W. Phillips, J. G. Hohmann, P. Wohnoutka, C. R. Gerfen, C. Koch, A. Bernard, C. Dang, A. R. Jones and H. Zeng (2014). &quot;A mesoscale connectome of the mouse brain.&quot; Nature 508(7495): 207-214.</p><p>Papathanou, M., S. Dumas, H. Pettersson, L. Olson and A. Wallen-Mackenzie (2019). &quot;Off-Target Effects in Transgenic Mice: Characterization of Dopamine Transporter (DAT)-Cre Transgenic Mouse Lines Exposes Multiple Non-Dopaminergic Neuronal Clusters Available for Selective Targeting within Limbic Neurocircuitry.&quot; eNeuro 6(5).</p><p>Patriarchi, T., J. R. Cho, K. Merten, M. W. Howe, A. Marley, W. H. Xiong, R. W. Folk, G. J. Broussard, R. Liang, M. J. Jang, H. Zhong, D. Dombeck, M. von Zastrow, A. Nimmerjahn, V. Gradinaru, J. T. Williams and L. Tian (2018). &quot;Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors.&quot; Science 360(6396): 1420-+.</p><p>Porter, L. L., E. Rizzo and J. P. Hornung (1999). &quot;Dopamine affects parvalbumin expression during cortical development in vitro.&quot; J Neurosci 19(20): 8990-9003.</p><p>Purcell, S. M., J. L. Moran, M. Fromer, D. Ruderfer, N. Solovieff, P. Roussos, C. O'Dushlaine, K. Chambert, S. E. Bergen, A. Kahler, L. Duncan, E. Stahl, G. Genovese, E. Fernandez, M. O. Collins, N. H. Komiyama, J. S. Choudhary, P. K. Magnusson, E. Banks, K. Shakir, K. Garimella, T. Fennell, M. DePristo, S. G. Grant, S. J. Haggarty, S. Gabriel, E. M. Scolnick, E. S. Lander, C. M. Hultman, P. F. Sullivan, S. A. McCarroll and P. Sklar (2014). &quot;A polygenic burden of rare disruptive mutations in schizophrenia.&quot; Nature 506(7487): 185-190.</p><p>Robbins, T. W. (2000). &quot;Chemical neuromodulation of frontal-executive functions in humans and other animals.&quot; Exp Brain Res 133(1): 130-138.</p><p>Rolls, E. T., M. Loh, G. Deco and G. Winterer (2008). &quot;Computational models of schizophrenia and dopamine modulation in the prefrontal cortex.&quot; Nat Rev Neurosci 9(9): 696-709.</p><p>Seamans, J. K. and C. R. Yang (2004). &quot;The principal features and mechanisms of dopamine modulation in the prefrontal cortex.&quot; Prog Neurobiol 74(1): 1-58.</p><p>Sesack, S. R., V. A. Hawrylak, C. Matus, M. A. Guido and A. I. Levey (1998). &quot;Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.&quot; J Neurosci 18(7): 2697-2708.</p><p>Soden, M. E., S. M. Miller, L. M. Burgeno, P. E. M. Phillips, T. S. Hnasko and L. S. Zweifel (2016). &quot;Genetic Isolation of Hypothalamic Neurons that Regulate Context-Specific Male Social Behavior.&quot; Cell Rep 16(2): 304-313.</p><p>Spear, L. (2000). &quot;Modeling adolescent development and alcohol use in animals.&quot; Alcohol Res Health 24(2): 115-123.</p><p>Stagkourakis, S., G. Spigolon, P. Williams, J. Protzmann, G. Fisone and C. Broberger (2018). &quot;A neural network for intermale aggression to establish social hierarchy.&quot; Nat Neurosci 21(6): 834-842.Sul, J. H., S. Jo, D. Lee and M. W. Jung (2011). &quot;Role of rodent secondary motor cortex in value-based action selection.&quot; Nat Neurosci 14(9): 1202-1208.</p><p>Sul, J. H., H. Kim, N. Huh, D. Lee and M. W. Jung (2010). &quot;Distinct roles of rodent orbitofrontal and medial prefrontal cortex in decision making.&quot; Neuron 66(3): 449-460.</p><p>Sulzer, D., S. J. Cragg and M. E. Rice (2016). &quot;Striatal dopamine neurotransmission: regulation of release and uptake.&quot; Basal Ganglia 6(3): 123-148.</p><p>Tseng, K. Y. and P. O'Donnell (2007). &quot;Dopamine modulation of prefrontal cortical interneurons changes during adolescence.&quot; Cereb Cortex 17(5): 1235-1240.</p><p>Vander Weele, C. M., C. A. Siciliano, G. A. Matthews, P. Namburi, E. M. Izadmehr, I. C. Espinel, E. H. Nieh, E. H. S. Schut, N. Padilla-Coreano, A. Burgos-Robles, C. J. Chang, E. Y. Kimchi, A. Beyeler, R. Wichmann, C. P. Wildes and K. M. Tye (2018). &quot;Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli.&quot; Nature 563(7731): 397-401.</p><p>Vijayraghavan, S., M. Wang, S. G. Birnbaum, G. V. Williams and A. F. Arnsten (2007). &quot;Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.&quot; Nat Neurosci 10(3): 376-384.</p><p>Wen, Z., H. N. Nguyen, Z. Guo, M. A. Lalli, X. Wang, Y. Su, N. S. Kim, K. J. Yoon, J. Shin, C. Zhang, G. Makri, D. Nauen, H. Yu, E. Guzman, C. H. Chiang, N. Yoritomo, K. Kaibuchi, J. Zou, K. M. Christian, L. Cheng, C. A. Ross, R. L. Margolis, G. Chen, K. S. Kosik, H. Song and G. L. Ming (2014). &quot;Synaptic dysregulation in a human iPS cell model of mental disorders.&quot; Nature 515(7527): 414-418.</p><p>Wood, J., Y. Kim and B. Moghaddam (2012). &quot;Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs.&quot; J Neurosci 32(9): 3022-3031.</p><p>Ye, Y., S. Mastwal, V. Y. Cao, M. Ren, Q. Liu, W. Zhang, A. G. Elkahloun and K. H. Wang (2017). &quot;Dopamine is Required for Activity-Dependent Amplification of Arc mRNA in Developing Postnatal Frontal Cortex.&quot; Cereb Cortex 27(7): 3600-3608.</p></body></sub-article></article>